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Cancer remains among the leading causes of death worldwide. In 2008, the International 
Agency for Research on Cancer (IARC) estimated the global risk of being diagnosed with cancer 
before age 75 to be 21.2% and 16.5% for men and women respectively [1]. The IARC estimated 
the risk of dying from cancer before age 75 to be 13.4% and 9.1% for men and women 
respectively. The figures become even more daunting when we consider the statistics for 
economically developed countries like the United States of America, where males under age 75 
have a 33.5% risk of being diagnosed with cancer, while women in the same category have a 
26.7% risk [1]. Why is it that despite intense and prolonged cancer research over the last 
decades the incidence and mortality of cancer remains so high? Cancer, it turns out, is a 
multifaceted disease with the ability to stem from and/or affect almost any cell in the body. And 
with hundreds of trillions of cells in the human body [2], the real question becomes - why is the 
rate of cancer so low? 
 
In an excellent review of the disease [3, 4], Hanahan and Weinberg described six 
features which a cell needs to acquire to become cancerous: (i) sustained stimulation of growth, 
(ii) resistance to tumor suppressor mechanisms, (iii) evasion of cell death, (iv) replicative 
immortality, (v) ability to activate angiogenesis and (vi) activation of metastasis and invasion. In a 
recent update they added four features that have consistently been associated with 
tumorigenesis: (a) evasion of immune destruction, (b) inflammation, (c) genomic instability and (d) 
deregulation of cellular energetics (Figure 1). Thus, it is undeniable that our own bodies do an 
enormous amount of work to ward of tumorigenesis and are extremely effective at doing so, at 
least while we are young. After age 40, the incidence of cancer dramatically increases [5] (Figure 
2), indicating age as one of the single highest risk factors for cancer. Unfortunately, unlike dietary 
and environmental factors we are as yet unable to limit our exposure to age, so we must develop 
a better understanding of the relationship between age and cancer. 
 
Research performed in the last few years has revealed important roles for the spatial and 
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A-type lamins, key structural components of the nucleus, have been implicated in the 
maintenance of nuclear architecture and chromatin organization [7, 9]. Mutations in A-type lamins 
have been associated with defects in a number of nuclear processes, including DNA replication 
and repair, and gene transcription and silencing [10, 11]. In support of an important role for 
nuclear organization in pathogenesis, mutations in A-type lamins are associated with a wide 
variety of degenerative diseases which range from muscular dystrophies and lipodystrophies to 
premature aging syndromes [12, 13]. In addition, alterations in the expression of A-type lamins 
are associated with different cancers such as small cell lung carcinoma and gastrointestinal 
neoplasms [14-17]. Despite the prevalent link between A-type lamins and disease, the molecular 
mechanisms behind lamins-associated pathogenesis are poorly understood. Elucidation of these 
mechanisms would provide insight into how nuclear organization affects genome function and 
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To advance the field, I have investigated the role of A-type lamins in the maintenance of 
genomic stability in mammalian cells. I present data showing novel functions for A-type lamins in 
the maintenance of the structure and nuclear distribution of telomeres, and the efficacy of the two 
major pathways of DNA double strand breaks repair, non-homologous end-joining (NHEJ) and 
homologous recombination (HR). Furthermore, I show that the mechanisms by which A-type 
lamins contribute to NHEJ and HR are distinct. A-type lamins maintain post-translational 
stabilization of 53BP1, which is an important NHEJ protein. In addition, A-type lamins maintain 
HR by regulating transcription of BRCA1 and RAD51, two essential HR factors. Importantly, the 
study of A-type lamins has led us to the discovery of a cysteine protease, cathepsin L, as a novel 
regulator of 53BP1 and the retinoblastoma tumor suppressor proteins. These findings are 
significant, because they reveal unexpected functions of A-type lamins and novel pathways that 
affect genomic stability. Our findings represent an important advance in understanding how 



















Normal cells are subject to strictly controlled signaling mechanisms which ensure 
controlled growth, proliferation, and death if necessary. Tumors arise from cells that not only 
escape these controls, but also acquire the ability to stimulate growth of new blood vessels for 
nutrient supply, escape replicative mortality, and migrate from the primary site of formation to 
invade other tissues [3, 4]. Genomic instability -abnormal alterations in the structure or sequence 
of the genome- increases the likelihood of acquiring these characteristics [3]. In hereditary 
cancers, it commonly results from defective DNA damage repair due to germline mutations in 
DNA repair genes such as BRCA1, BRCA2 and WRN [18]. However, the cause of initial genomic 
instability in non-hereditary (sporadic) cancers is much less clear. Prior to therapy, sporadic 
cancers are not characterized by frequent mutations in DNA repair genes. Instead, the genomic 
instability is speculated to arise from other factors such as oncogenic mutations of caretaker 
genes like TP53 [18]. Defects in telomere biology and DNA damage repair are among the leading 
causes of genomic instability in cancer and aging. 
(ii)Telomeres	
Semi-conservative replication of DNA presents a unique problem for linear 
chromosomes. Since DNA polymerase moves in a 5’ to 3’ direction and requires RNA primers to 
begin synthesis, the very ends of the lagging strand DNA are not replicated (the “end replication 
problem”) [19]. Thus, there is loss of genomic DNA with successive bouts of replication and cell 
division [19]. The presence of telomeres, highly conserved specialized nucleoprotein structures 
found at the end of linear chromosomes, helps to ameliorate this problem [20]. Telomeres serve a 
number of essential functions on chromosomes: (i) they buffer loss of genomic DNA due to the 
end replication problem, (ii) their specialized structure protects the ends of chromosomes from 
nucleolytic processing, (iii) they distinguish the ends of linear chromosomes from DNA double-




Normal somatic cells undergo telomere attrition with each round of cell division [21, 22]. 
When telomeres reach a critically short length, proliferation is halted as cells enter senescence, 
an irreversible state of cell cycle arrest [23, 24]. Cells that are able to bypass senescence 
continue dividing until the telomeres become so short as to trigger a second crisis, which is 
characterized by profound genomic instability that causes massive cell death[23]. Cancer cells 
acquire immortality by activating telomere lengthening mechanisms. 80-90% of cancers 
upregulate telomerase, a ribonucleoprotein enzymatic complex that is capable of performing de 
novo telomere extension [25-29]. Other cancers activate alternative lengthening of telomeres 
(ALT), a process which involves extension by recombination between telomere sister chromatids 
[30-33]. Telomere maintenance allows cancer cells to survive crisis [34] and attain unlimited 
replicative potential - immortalization [24, 35]. Inhibition of telomerase activity is under active 
research as a potential anticancer therapy [36-38]. 
 
While the length of the telomere is extremely important for its function, its tertiary 
structure is no less important. Human and mouse telomeres are composed of double stranded 
DNA (dsDNA) 5’ to 3’ TTAGGG repeats, capped off by a G-rich 3’ overhang of single stranded 
DNA [39]. The G-rich overhang folds back onto the dsDNA and invades its complementary base 
pairing in a D-loop structure, forming a larger T-loop tertiary structure (Figure 3). Formation of the 
T-loop is facilitated by the shelterin complex which is composed of six proteins: the dsDNA 
binding TRF1 and TRF2, the ssDNA binding POT1, and the ancillary proteins TPP1, TIN2 and 
Rap1 [20, 40]. TRF1 and TRF2 bind directly to TTAGGG repeats and are present in the complex 
as homodimers. TPP1 and POT1 form a heterodimer with high affinity for the G-strand overhang, 
while TIN2 tethers TPP1/POT1 to TRF1 and TRF2, contributing to the stabilization of the complex 
[40-49]. All six proteins are necessary for maintenance of the tertiary structure, however TRF2 
and TPP1-POT1 are notable for their role in preventing the telomeres from being recognized as 
DNA breaks by the DNA damage repair pathway. Removal of TRF2 or TPP1-POT1 shunts 
telomeres to the non-homologous end joining (NHEJ) DNA damage repair pathway [50, 51]. This 















































































































































































polymerase II [58, 59]. TERRAs are emerging as inhibitors of telomerase activity and have been 
implicated in both the assembly of telomeric heterochromatin and regulation of telomere 
replication. Upregulation of TERRAs in S. cerevisiae resulted in telomere elongation and was 
associated with replication defects which resulted in increased sensitivity to hydroxyurea [60, 61]. 
Thus, the coordinated action of telomere length maintenance mechanisms and telomere binding 
proteins is essential for preserving the role of telomeres in ensuring genomic stability.  
(iii)The	DNA	damage	response	(DDR)		
Cells are constantly subjected to DNA damage from exogenous factors such as UV 
irradiation, and endogenous factors such as oxidative damage from metabolic processes, 
replication errors or aberrant activation of nucleases [62]. In addition to accidental DNA damage, 
some normal physiologic processes such as variable diversity and joining (VDJ) recombination 
and class switch recombination (CSR) in developing lymphocytes, involve deliberate formation of 
DNA breaks and require specific mechanisms of repair [63]. The presence of unrepaired double-
strand breaks (DSBs) can be especially deleterious as it can trigger cell cycle arrest or even cell 
death when the damage is beyond repair [62]. Similarly, use of inappropriate repair mechanisms 
can cause genomic instability due to loss of genomic material or chromosomal translocation[64]. 
To counter the assaults on genomic integrity, cells have developed a DNA damage response 
pathway and a variety of specialized mechanisms for repair of DNA DSBs (Figure 4 and Table 1). 
 
All organisms respond to DNA damage by launching the DNA damage response (DDR) 
[65, 66]. The DDR can be considered a signal transduction pathway where damaged DNA is 
detected by “sensors” that trigger the activation of a signaling cascade composed of protein 
kinases of the PIKK family – ATM (Ataxia telangiectasia mutated) and ATR (Ataxia Telangiectasia 
and Rad3 related) [67, 68]. The kinase cascade amplifies and transduces the initial DNA damage 
signal and triggers activation of “effector” proteins that activate cell cycle arrest or repair the 
damaged DNA. In mammalian cells, a DNA DSB is recognized by the MRN (Mre11/RAD51/Nbs1) 
sensor complex, which recruits ATM to the damage site. Once recruited, ATM undergoes 
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autophosphorylation and monomerization, and initiates the phosphorylation of a number of 
substrates implicated in different aspects of DNA repair such as Nbs1, the histone variant H2AX, 
and the tumor suppressor protein BRCA1. Additionally, ATM activates proteins involved in cell 
cycle arrest such as p53 and Chk2. This is particularly essential as it ensures that damaged DNA 
is repaired prior to DNA replication. Activation of the DDR results in repair of the DSB by either 
homology directed repair or non-homologous end-joining. The repair process generally includes 
processing of the end to remove damaged DNA, strand fill-in by DNA polymerases and finally 
ligation of opposite ends of the break [62, 69]. The extent of DNA end-resection during 
processing and the mechanism used for strand fill-in differ significantly between the two major 
forms of DSB repair - homology directed repair and non-homologous end-joining. 
Intentional DNA double-strand 
breaks
•Variable diversity and joining 
(V(D)J  recombination)
•Class switch recombination





Accidental DNA double-strand breaks
•Exogenous damage (ionizing radiation etc.)
•Endogenous damage (oxidative free 





•Single strand annealing (SSA)
Repaired break
 
Figure  4. Mechanisms  of DNA  double  strand  break  repair.  Physiologic  breaks  such  as  those 
induced during  immune cell development processes  like V(D)J  recombination and class switch 
recombination are targeted for repair by non‐homologous end  joining (NHEJ). Pathologic DSBs 
such  as  those  occurring  upon  exposure  to  ionizing  radiation,  or  free  radical  attack  can  be 
targeted  for repair by NHEJ or by homology directed repair  (HDR) depending on  the cell cycle 
phase.  As opposed to HR, NHEJ is error prone and likely to result in alterations in the genomic 
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Homology directed repair occurs under diploid conditions such as during meiosis or S/G2 
phases of mitotic cells. Of the three types of HDR mechanisms -homologous recombination, 
single strand annealing and break-induced replication- homologous recombination is most 
frequently used [70]. Homologous recombination (HR) is possible during S/G2 phases of the cell 
cycle where DNA replication has produced sister chromatids to be used as templates for 
recombination. In the event of a DSB, there is extensive end resection of one strand of the DNA 
to reveal a 5’ - 3’ single strand overhang. ssDNA formed by end resectioning is coated with a 
ssDNA binding protein complex, RPA, which removes secondary structures on the DNA strand. 
Next, displacement of RPA on ssDNA by RAD51 forms the essential presynaptic filament, which 
facilitates the search for regions of homology, strand invasion and subsequent strand fill in by 
DNA polymerase [70-73]. The exact mechanism of DNA end resectioning in vertebrates remains 
unclear and seems to involve a number of different nucleases [73]. Recent studies have identified 
the mammalian protein CtIP as having an essential role in end resection, as depletion of CtIP 
leads to severe inhibition of the formation of ssDNA [74-79]. The role of CtIP in end resection 
relies on the ability of the phosphorylated form of the protein to interact not only with BRCA1, 
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which facilitates its recruitment to DSB sites [80, 81], but also with Mre11, a DNA damage sensor 
which possesses nuclease activity [73, 77, 82]. While the mechanism by which CtIP promotes 
end-resection is unclear, its recruitment is proposed to be a “switch” which facilitates end-
resection of DSBs, in conjunction with MRN [79]. However the possibility remains that CtIP itself 
has nucleolytic activity, as has been shown for the S. cerevisiae homolog Sae2 [73].  
 
BRCA1 functions as a tumor suppressor and mutations in the gene are commonly 
associated with breast and ovarian cancer [83-85]. The role of BRCA1 as a tumor suppressor 
stems from its essential role in facilitating formation of ssDNA during homologous recombination 
[86, 87]. BRCA1-deficient cells display significant reduction in the formation of ssDNA and 
subsequent recruitment of ssDNA binding proteins such as RPA and RAD51. Recent reports 
have established BRCA1 as a “competitor” against the NHEJ protein 53BP1 for DSB repair 
substrate [88-91]. These studies showed that loss of BRCA1 was associated with decreased HR 
and increased formation of aberrant chromosomal structures, and that this phenotype was 
reversed by decreasing 53BP1. The authors speculated that in the absence of BRCA1, DSBs that 
would normally be fixed by HR are retargeted for NHEJ by 53BP1, leading to ligation between 
incompatible DSBs which result in aberrant chromosome structures [90]. Removing 53BP1 is 
postulated to reduce this NHEJ pressure, which increases the competitive ability of HR. Thus, 
53BP1-mediated NHEJ is a direct competitor of BRCA1-mediated HR. Activation of HR in the 
absence of sister chromatids could result in recombination between homologous regions of non-
sister chromatids, which could cause loss of heterozygosity, or chromosomal translocations if 
non-allelic sequence templates are used [70]. Interestingly, Shibata A. et al. recently reported that 
NHEJ is used as the first attempt for DSB repair even during the G2 phase of the cell cycle of 
human fibroblasts [92]. The authors propose that components of THE NHEJ pathway are 
preferentially recruited to DSBs, but in the event of structural complexities at the lesion, the NHEJ 




NHEJ is dominant during G0/G1 and early S phase. It relies on ligation between DSB 
ends that have undergone minimal processing [93]. Upon recognition of a DSB, the Ku70/Ku80 
heterodimer encircles the DNA end and helps to recruit DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs), a member of the PIKK family of protein kinases. DNA-PKcs undergoes 
autophosphorylation and phosphorylates a number of proteins at the break site [63, 94]. 
Recruitment of the DNA processing enzyme Artemis follows activation of DNA-PKcs kinase 
activity. Artemis is important for the formation of 5’-phosphorylated ligatable DNA ends putatively 
through it’s exo- and endonuclease activities [95-97]. Further processing such as gap-fill in by 
DNA polymerases (μ and λ) might be required to prepare the DNA ends for ligation [63]. Once 
compatible ends have been formed ligation occurs by a complex containing XRCC4, a ku 
interacting protein, and the ligating enzyme DNA ligase IV. The ligation step is significantly 
different from HR, as it requires neither significant end-resection nor homologous sequences for 
strand fill-in by DNA polymerase. 
 
The ku70/80 heterodimer can interact with and recruit nucleases, polymerases and the 
ligase complex in any order [63]. This allows flexibility in the sequence of processing events at 
the DSB site, with the result that a single DSB can yield different DNA sequences at the region of 
ligation. For example, a break that is processed by a nuclease and then a polymerase will be 
different from one that is processed by a nuclease and then a DNA ligase. Further diversity might 
occur from recruitment of polymerase μ, which is capable of template-independent DNA 
synthesis for strand fill-in. Thus, unlike HR, NHEJ is inherently associated with alterations of the 
DNA sequence at the site of repair. While NHEJ is more error prone than HR it is essential not 
only for the timely repair of pathogenic DSBs, but also for endogenous processes which involve 
deliberate formation/repair of DSBs, such as class switch recombination (CSR) and variable 
diversity and joining recombination (VDJ) in lymphocytes [98-100]. Mutations in NHEJ genes are 




Along with this “classic” form of NHEJ (C-NHEJ), recent work has begun to demonstrate 
the importance of a less understood pathway designated “alternative-NHEJ” (A-NHEJ) pathway 
[93, 103, 104]. A-NHEJ is distinct from C-NHEJ in its requirement for short regions of 
microhomology between ligatable ends of DNA [93, 105]. A-NHEJ relies on CtIP-mediated 
resection of DNA to reveal short regions of homology, which then undergo ligation primarily 
mediated by DNA ligase III [104, 106]. Unlike homologous recombination, DNA that is resected 
during A-NHEJ does not undergo strand fill-in from a homologous sequence, so there is 
permanent loss of DNA sequence, making it a potentially more deleterious pathway than C-NHEJ 
or HR. In line with this idea, A-NHEJ was reported to play a primary role in the formation of 
chromosomal translocations in mouse embryonic stem cells [103]. 
(vi)	p53	Binding	Protein	1	(53BP1)	
53BP1 was initially discovered in 1994 in a yeast two-hybrid screen as a p53-interacting 
protein [107]. Since its discovery it has been demonstrated to play significant roles in DSBs repair 
pathways with a primary role in NHEJ of long-range DNA breaks and an indirect role as a 
suppressor of other pathways of DSBs repair [108-112]. 53BP1 is necessary for efficient repair of 
non-pathogenic “long-range” DSBs such as those that occur during V(D)J recombination or class-
switch recombination in immune cell development and maturation [51, 98-100, 113]. Maturation of 
the immune system B and T lymphocytes involves generation of DSBs by RAG1 and RAG2 
endonucleases at recombination signal sequences on different gene segments (Variable, 
Diversity and Joining). Ligation of the DSBs produces the heavy and light immunoglobulin chains 
during maturation. 53BP1 was shown to be necessary for joining between distal (long-range) 
sequences, but dispensable for short range end-joining. Consistent with these roles, 53BP1-/- 
mice suffer a significant reduction in the formation of B & T cell lineage cells [100]. Similarly, 
53BP1 is necessary for long range DSBs end joining which occurs in class switch recombination 
during B cell activation, and also in the processing of telomeres that are rendered deprotected by 
loss of the TRF2 shelterin complex component [51, 98]. The mechanism by which 53BP1 
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promotes end-joining between distal DSBs is unclear, but thought to involve promotion of 
synapsis, chromatin relaxation and possibly regulation of the mobility of DSBs [114, 115]. 
 
A number of unresolved questions remain regarding the role of 53BP1 in repair of 
different forms of DNA DSBs. For example, 53BP1 is immediately recruited to DSBs induced by 
ionizing radiation (IR), however loss of 53BP1 has only a mild effect on the repair of IR-induced 
breaks. Furthermore, the necessity for 53BP1 seems to depend on the amount of DSBs that are 
present, such that 53BP1 has a bigger impact on the repair of low levels of DSBs, putatively 
through its ability to promote recruitment of the MRN complex (which then promotes ATM 
recruitment) via binding of Rad50 to the BRCT domain of 53BP1 [111, 114, 116]. It is speculated 
that high levels of IR-induced DSBs can sufficiently stimulate MRN recruitment and activation of 
ATM, while low levels stimulate only a mild DDR, and thus require assistance from 53BP1 [114]. 
Recent work demonstrating a specific role for 53BP1 in late-repairing heterochromatic DSBs has 
begun to shed light on these issues, showing why 53BP1 might only be required for repair of a 
subset of IR-induces breaks. A.T. Noon and colleagues [114] demonstrated that 53BP1 promotes 
localization of phosphorylated KAP-1 (pKAP-1, KRAB Associated Protein-1) at late repairing 
heterochromatic DSBs that were induced by IR. pKAP-1 promotes repair of heterochromatic 
DSBs by inhibiting the function of CHD3, an ATP dependent chromatin remodeling enzyme which 
promotes nucleosome compaction [117]. Thus, 53BP1 plays a significant role in repair of breaks 
in heterochromatic regions of the genome by affecting chromatin structure.  
 
Recent work revealed that 53BP1 suppresses HR and A-NHEJ putatively by binding to 
DSBs and inhibiting end-resection [90, 118]. Further work is required to clarify the exact 
mechanism of inhibition; however the implication of 53BP1 in other repair pathways is exciting, as 
it suggests novel approaches for cancer therapy. A number of elegant studies recently 
demonstrated that loss of 53BP1 can reverse some of the phenotypes associated with BRCA1 
deficiency [89-91]. In particular, cells double null for BRCA1 and 53BP1 exhibit a much lower 
degree of genomic instability and have increased survival when treated with DNA damaging 
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agents. These studies demonstrate that loss of 53BP1 is “synthetically viable” with BRCA1 loss 
[88]. The current view is that loss of BRCA1 results in defective end-resection of DNA DSBs. In 
this context, accumulation of 53BP1 at the breaks promotes NHEJ. 
 
The interplay between 53BP1 and the HR pathway is functionally important, as it could 
contribute to the development of resistance of BRCA1-mutated cancers to treatment with DNA 
damaging agents. A major breakthrough in the treatment of BRCA1-mutant tumors was the 
finding that these types of tumors are very sensitive to poly(ADP-ribose) polymerase inhibitors 
(PARPi) [119, 120]. The targets of PARPi are PARP1 and the closely related PARP2 proteins, 
which are activated at sites of DNA breaks to catalyze the formation of poly(ADP-ribose) 
polymers both on themselves as well as other substrates [121-124]. Inhibition of PARP activity 
hinders repair of single stranded DNA breaks, which are converted to DSBs if encountered by a 
replication fork during DNA synthesis in S-phase. [120, 125]. Since DSBs are primarily repaired 
by HR during S-phase, lack of BRCA1 impairs repair of these DSBs and leads to activation of cell 
cycle arrest and/or cell death. Thus, treatment of BRCA1-mutated cells with PARPi is a way to 
selectively induce death. Despite the promising results of phase 2 trials the first phase 3 clinical 
trial with iniparib, the most advanced PARPi, was disappointing as it did not improve patient 
survival [126]. Given that double deficiency of BRCA1 & 53BP1 in mouse cells promotes 
resistance to PARPi, it is likely that loss of 53BP1 is one of the key mechanisms activated by 
BRCA1-mutated tumors to develop resistance to PARPi. This is supported by the fact that there 
is decreased 53BP1 expression in a subset of BRCA1-associated breast cancers and that loss of 
53BP1 is associated with a decreased likelihood of survival in breast cancer patients [88, 89]. 
Thus, 53BP1 is a key player in DNA damage repair and genomic stability, directly through its role 





The likelihood of being diagnosed with cancer increases exponentially with age, up until 
age 75 (Figure 2) [5], making age one of the greatest “risk factors” for cancer. In recent years, a 
number of studies addressed whether or not age actually contributes to tumorigenesis or is 
merely associated with it. This question has posed difficult to answer, as cancer and aging are 
characterized by many of the same features such as genomic instability, cellular senescence, 
autophagy and alterations in telomere biology [127]. Intriguingly, a number of human diseases 
present with mutations in factors that are involved in DNA replication and the DDR pathways 
[128] (See table 2). A whole body of evidence indicates that mutations in factors involved in DNA 
replication, the DDR pathway or mechanisms of DNA repair result in premature aging and 
increased cancer susceptibility [128-130]. 
 
Mutations in the gene coding for Werner protein (WRN) give rise to Werner Syndrome, a 
premature aging disease which associates with increased risk of cancer, especially carcinomas 
and sarcomas [130]. WRN is a member of the RecQ family of DNA helicase and displays both 
helicase and exonuclease activity, which are necessary for DNA replication. Patients afflicted with 
Werner Syndrome present with premature aging which begins to manifest in early adulthood with 
features such as grey hair, wrinkled skin, bone loss, diabetes type II and atherosclerosis. Cells 
from these patients are characterized by increased chromosomal instability and prolonged S-
phase [131, 132]. A report on cells from a Werner Syndrome patient indicated abnormalities in 
nuclear shape, such as nuclear invaginations and protrusions, suggesting possible defects in 
nuclear organization [133]. Interestingly, several heterozygous mutations in the LMNA gene, 
which codes for the nuclear structural proteins lamin A and lamin C, also cause a similar 
phenotype, Atypical Werner Syndrome, which features premature aging, bone loss and diabetes 
[134-136]. However, there have been no reports on genomic instability in LMNA-associated 






Premature Aging Syndromes Associated with 
Mutations in DNA Repair Genes 
Ataxia Telangiectasia (ATM) 
Werner Syndrome (WRN) 
Bloom Syndrome (BLM) 
Dyskeratosis Congenita (DKC1, TERC) 
Aplastic Anaemia (TERC, TERT) 
Fanconi Anemia (Fanc genes) 
Nijmegen Breakage Syndrome (NBM) 
 
Another interesting link between A-type lamins and premature aging is manifested by the 
most severe premature aging disease, Hutchinson-Gilford Progeria Syndrome (HGPS) [137-140]. 
HGPS arises due to a mutation in the LMNA gene which results in production of a mutant protein, 
progerin. Children with HGPS appear normal at birth but within a year they begin to manifest 
characteristic features of aging such as shortened stature, craniofacial disproportion, alopecia 
(hair loss), osteoporosis and abnormal distribution of fat. These children die very young, usually 
by their early teens, due to severe atherosclerosis and cardiovascular complications. 
Interestingly, progerin has also been shown to accumulate in cells from aged individuals, further 
implicating A-type lamins in aging and tumorigenesis. Along these lines, HGPS fibroblasts 
undergo faster telomere attrition than their normal counterparts and have global defects in the 
epigenetic marks characteristic of constitutive heterochromatin [22, 141]. Given the 
commonalities between aging and cancer and the link between A-type lamins and premature 
aging, we speculate that the molecular mechanisms responsible for the pathogenesis of LMNA 




A-type lamins are type V intermediate filaments found exclusively in the nuclei of 
differentiated cells [12, 142, 143]. The major products of the LMNA gene are lamin A and its 
smaller splice variant lamin C, which lacks 92 amino acids at the C-terminus. Minor products of 
the LMNA gene are lamin A∆10 and lamin C2, a testis specific protein [144]. A-type lamins are 
expressed only in differentiated cells and are absent during embryogenesis up until mouse 
embryonic day 12, where tissue-specific expression becomes apparent [145]. While most adult 
tissues express A-type lamins a few, including cells of the immune system such as B and T 
lymphocytes, cells isolated from the bone marrow, and pancreatic islets, show little to no 
expression [146].  
 
Within the nucleus, A-type lamins form coiled-coil filaments that are juxtaposed to the 
inner nuclear membrane as a filamentous mesh that interacts with locally distributed proteins 
such as integral nuclear membrane proteins, B-type lamins and lamins-associated proteins (LAP) 
[144]. A fraction of lamin A/C extends throughout the nucleoplasm where they also interact with 
numerous proteins involved in cell cycle regulation, including Rb and PCNA [147-149]. Initial 
translation of the LMNA transcripts yields mature lamin C and a premature form of lamin A, 
prelamin A, which undergoes extensive post-translational processing to yield the mature form. 
Prelamin A contains a C-terminus CAAX motif which is targeted for farnesylation for attachment 
to the inner nuclear membrane. Following farnesylation, the Zmpste24 enzyme cleaves prelamin 
A at a specific site within the C-terminus. This cleavage relieves lamin A of its farnesylation and 
produces mature lamin A. A-type lamins are thought to play a scaffolding role for tethering 
chromatin to specific sub-compartments, which in turn serves to organize nuclear processes [7, 9, 
12, 150]. In fact, depletion of A-type lamins or expression of mutant forms of the proteins leads to 
defects in chromatin remodeling and in the 3D organization of the genome, as exemplified by loss 
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Alterations in the processing of lamins A/C, either through mutations in the LMNA gene or 
the processing enzymes, can lead to pathogenesis. In particular, mutations in the LMNA gene are 
associated with a number of degenerative diseases, collectively termed laminopathies, which are 
divided into two broad non-exclusive categories: diseases that affect striated muscle (muscular 
dystrophies) and diseases that affect adipose tissue (lipodystrophies) and bone [12, 142, 154]. 
The muscular dystrophies are characterized by wasting or lack of development of muscular tissue 
and include autosomal dominant emery-dreyfuss muscular dystrophy (AD-EDMD), limb-girdle 
muscular dystrophy 1B (LDMD1B) and dilated cardiomyopathy (DCM). Diseases of the adipose 
tissue and bone feature hyperlipidemia, aberrant distribution of white adipose tissue, and 
sometimes abnormal bone structure in diseases such as familial partial lipodystrophy (FPLD) and 
mandibuloacral dysplasia (MAD). In an overlapping phenotype, mutations in A-type lamins can 
feature defects in both adipose tissue and bone structure, as well as defects in striated muscle, 
as seen in HGPS, a severe premature aging disease. HGPS is caused by a single mutation 
(1824C>T, G608G) which results in activation of a cryptic splice site within the LMNA gene, 
leading to removal of the Zmpste24 cleavage site [140, 155]. This aberrant version of lamin A 
(known as progerin) is still farnesylated, however absence of the Zmpste24 cleavage site 
prevents further processing and it accumulates at the nuclear membrane, causing abnormalities 
in the nuclear shape such as nuclear blebbing and invagination [139]. 
(x)	Mouse	models	of	laminopathies	
In an effort to understand the pathogenesis behind LMNA mutations, several groups have 
developed mouse models of various laminopathies [156]. These mouse models of laminopathies 
have ranged from deletion of the LMNA gene (Lmna-/-) or a lamin A-processing enzyme 
(Zmpste24-/-) to introduction of various mutations in the LMNA gene [151, 157]. The different 
mouse models reproduce varying spectrum of human laminopathies. The Lmna-/- and Zmpste24-/- 
mice have been most extensively characterized. Zmpste24-/- mice are normal at birth up until 4 
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weeks, after which they present decreased growth rate, size, abnormal posture, muscular 
dystrophy and loss of subcutaneous fat [157, 158]. These mice eventually succumb to death 
within 20 weeks due to dilated cardiomyopathy and heart failure. The Lmna-/- mice are very 
similar to the Zmpste24-/-, showing growth retardation, lipodystrophy, muscular dystrophy, cardiac 
and skeletal myopathy and death within 8 weeks [151]. Most of what we currently understand 
about the role of A-type lamins in pathogenesis has been gleaned from studies in the mouse 
models of laminopathies. 
 
A-type lamins function in a number of nuclear processes, including positioning of nuclear 
pore complexes, interaction with chromatin, DNA synthesis and transcription [10, 11, 159]. 
However, the exact molecular mechanisms behind the function of lamins in these processes 
remain undefined. Studies from the Zmpste24-/- mice as well as cells from HGPS patients have 
shed some light on the mechanisms which might contribute to pathogenesis. Bone marrow cells 
from the Zmpste24-/- mice have increased genomic instability, characterized by chromosome 
breaks and presence of γ-H2AX foci, while fibroblasts from HGPS patients and Zmpste24-/- mice 
have alterations in the DDR [152, 160]. At a molecular level, HGPS and Zmpste24-/- MEFs 
showed delayed recruitment of 53BP1 to DNA repair foci upon treatment with ionizing radiation, 
and delayed disappearance of these foci [152]. Interestingly, Zmpste24-/- MEFs are thought to 
have enhanced NHEJ, based on their increased ability to efficiently re-join a linearized plasmid 
after transient transfection. Zmpste24-/- MEFs also showed impaired recruitment of RAD51 to 
sites of DNA damage leading to a delayed checkpoint response and defective DNA repair, 
suggestive of impaired HR [152]. In additional support of a role for A-type lamins in the DDR, 
ectopic expression of mutant forms of lamin A in the presence of wild-type lamin A/C was 
sufficient to inhibit formation of γ-H2AX-labeled DNA repair foci in response to mild doses of 
cisplatin or UV irradiation [161]. All these reports suggest that unprocessed prelamin A and 





Aberrant nuclear morphology and changes in the nuclear lamina are emerging as 
characteristic features of cancer cells [8]. This suggests that factors that are important 
determinants of nuclear architecture might be relevant for understanding tumorigenesis. In fact, 
the expression of A-type lamins has been shown to be altered in a number of malignancies 
including small cell lung carcinoma (SCLC) and certain types of gastrointestinal neoplasms [14, 
17, 162, 163]. Furthermore, A-type lamins are implicated in a variety of pathways that are 
involved in genomic instability and tumorigenesis. One of the most notable pathways involves the 
stabilization of the retinoblastoma tumor suppressor proteins pRb and p107 by A-type lamins. 
Using cells from wild-type and Lmna-/- mice, Johnson et al. (2004) demonstrated interaction 
between A-type lamins and pRb, and that loss of A-type lamins leads to increased proteasomal 
degradation of pRb and p107 [148]. Given the significant roles of pRb and p107 as bona-fide 
tumor suppressors [164], the mechanism by which they are regulated is of relevance to this field. 
However, studies attempting to understand the mechanism of lamins-dependent pRb/p107 
degradation have only managed to demonstrate that MDM2 and gankryin, the pathways currently 
known to regulate their stability, are not involved in this process [165]. Thus loss of A-type lamins 
leads to degradation of pRb/p107 by a mechanism that has remained elusive.  
 
Given that A-type lamins are strongly implicated in aging and are emerging to be relevant 
for cancer, we hypothesized that they are involved in the maintenance of genomic stability. To 
test this hypothesis we investigated various components of genomic instability, such as 
alterations in telomere biology, chromosomal structure and the efficacy of DNA damage repair 
pathways in lamin A/C-proficient or deficient mouse and human cells. Strikingly, we found that 
lamin A/C-deficiency was associated with gross abnormalities in telomere structure and nuclear 
organization, as well as significant inhibition of the two major pathways of DNA DSBs repair. Our 
studies reveal a novel relationship between A-type lamins and both NHEJ and HR: A-type lamins 
promote NHEJ through stabilization of 53BP1, whereas they promote HR by transcription of 
BRCA1 and RAD51 genes. Furthermore, these studies have led to the discovery of new 
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pathways that are involved in the regulation of 53BP1 and the retinoblastoma pocket family 




























Research performed in the last few years has revealed important roles for the spatial and 
temporal organization of the genome on genome function and integrity. A challenge in the field is 
to determine the molecular mechanisms involved in the organization of genome function. A-type 
lamins, key structural components of the nucleus, have been implicated in the maintenance of 
nuclear architecture and chromatin structure and have a prevalent connection to disease. 
Mutations in the LMNA gene are linked to a wide variety of degenerative disorders termed 
laminopathies, whereas changes in the expression of lamins are associated with tumorigenesis. 
However the molecular pathways affected by alterations of A-type lamins and how they contribute 
to disease are poorly understood. To gain insight into the mechanisms that contribute to 
pathogenesis, we determined whether loss of A-type lamins affects overall genomic stability and 
telomere homeostasis in LMNA knockout mouse fibroblasts. Intriguingly, we find that loss of A-
type lamins alters the nuclear distribution of telomeres and is also associated with telomere 
attrition, defective assembly of telomeric heterochromatin, and increased chromosomal instability. 
This study reveals new functions for A-type lamins in the maintenance of genomic integrity and 
suggests that alterations of telomere biology may contribute to the pathogenesis of lamin-related 
diseases. 
1.1	Altered	nuclear	organization	of	telomeres	
Three dimensional (3D) analysis of telomere positioning indicates that mammalian 
telomeres are distributed throughout the entire nuclear volume in G0/G1/S phases of the cell 
cycle, whereas they assemble into a telomeric disk at the center of the nucleus during G2 in 
preparation for mitosis [166]. The molecular mechanisms that ensure proper nuclear localization 
of mammalian telomeres and their relevance in telomere metabolism remain undefined. 
Interestingly, the 3D positioning of telomeres is altered in tumor cells [167] and in senescent cells 
presenting defects in the nuclear lamina [168], suggesting a relationship between nuclear 
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distribution of telomeres and alterations of telomere metabolism observed during senescence and 
immortality. 
 
To determine whether A-type lamins have a role in the nuclear compartmentalization of 
telomeres, we compared the distribution of telomeres between wild-type (Lmna+/+) mouse 
embryonic fibroblasts (MEFs) and MEFs devoid of A-type lamins (Lmna-/-). MEFs were analyzed 
after spontaneous immortalization in culture. Cells were subjected to 3D telomere fluorescence in 
situ hybridization (3D-FISH), imaged and analyzed for telomere distribution (Figure 6A). The 
distances of each telomere to the nuclear edge was determined using the TeloView program 
[169]. We found a clear difference in telomere distribution between the two genotypes (Figure 
6B), such that lamins-deficient cells had a shift in the localization of telomeres towards the 
nuclear periphery. By calculating the cumulative distribution of telomere intensities we show that 
approximately 20% of telomere signals were found at the very edge of the nucleus (≤0.4 μm) in 
both genotypes (Figure 6C). However, although the remaining 80% of telomeres in Lmna-/- cells 
accumulated within a distance of 1.75 μm from the edge, telomeres in Lmna+/+ MEFs were more 
dispersed throughout the nucleoplasm.  
 
These results clearly show that A-type lamins participate in the correct distribution of 
telomeres throughout the entire nuclear volume, with a significant shift in distribution towards the 
nuclear periphery and away from the nuclear centre upon loss of A-type lamins. Fluorescence-
activated cell sorting analysis carried out on proliferating Lmna-/- and Lmna+/+ immortalized 
fibroblasts indicated that changes in telomere distribution were not due to differences in cell-cycle 
profiles between genotypes [170]. In addition, chromatin immunoprecipitation (ChIP) assays 
performed using lamin A/C antibody showed binding of lamins to telomeres [170], suggesting that 



























































































































To determine whether changes in telomere distribution upon loss of A-type lamins are 
accompanied by alterations of telomere metabolism, we compared telomere length between 
multiple sets of Lmna+/+ and Lmna-/- MEFs of early passage (pre-senescent). Analysis by terminal 
restriction fragment (TRF) [171] showed faster migration of telomeres in all five Lmna-/- lines 
compared to Lmna+/+ lines, indicating a moderate but highly consistent telomere shortening upon 
loss of A-type lamins (Figure 7A). These results were confirmed by quantitative fluorescence In 
situ hybridization (Q-FISH) [171] of metaphase nuclei using a telomeric probe. While mean 
telomere lengths of Lmna+/+ lines ranged between 37.6 and 40.8 kb, with an average telomere 
length of 39.0 kb, all five lines of Lmna-/- MEFs presented lower mean telomere length than any of 
the Lmna+/+ lines, ranging between 34.0 and 35.2 kb, with an average telomere length of 34.6 kb 
(Figure 7B). To determine whether these differences were statistically significant, we carried out a 
two-sided t-test considering the mean from each of the cell lines to be an independent sample of 
either Lmna+/+ or Lmna-/- genotype. We found that the mean telomere length is significantly 
different between these two genotypes (P=0.0003). In addition, TRF analysis of adult fibroblasts 
from Lmna-/- mice also showed a more pronounced telomere shortening phenotype [170].  
 
To test whether acute depletion of A-type lamins would also lead to telomere attrition, we 
lentivirally transduced wild-type MEFs with constructs carrying shRNA specific for depletion of A-
type lamins (shLmna) or shRNA specific for luciferase (shLucif) as control. Transduction using 
shLmna led to undetectable levels of lamin A/C (Figure 7C). Telomere length analysis by Q-FISH 
revealed a marked decrease in telomere length after only five passages of the cells in culture 
(Figure 7D). Most importantly, reintroduction of either lamin A, lamin C, or both, by retroviral 
transduction of A-type lamins-depleted cells rescued the telomere shortening phenotype to 
varying degrees (Figure 7D). Overall, reintroduction of lamins led to a significant increase in 
average telomere length, as well as a decrease in the pool of short telomeres and an increase in 




















































































































These data indicate that A-type lamins play a key role in the control of telomere length. 
However, we do not know the mechanism behind the telomere shortening phenotype observed in 
A-type lamins-deficient cells. The levels of telomerase activity and the binding of the shelterin 
complex components TRF1 and TRF2 were not affected by the loss of A-type lamins [170]. 
Similarly, we did not observe any evidence of aberrant recombination at telomeres, which could 
explain the loss of telomeric sequences [170]. It is possible that the binding of other shelterin 
complex components or DNA repair factors with a function at the telomere could be defective in 
LMNA null cells. Alternatively or concomitantly, loss of A-type lamins might hamper the 
accessibility of telomerase or other proteins implicated in telomere metabolism, especially factors 
implicated in telomere replication. While the mechanisms remain unclear, our data clearly show 
that A-type lamins have a key role in the maintenance of telomere length homoeostasis. 
1.3	Abnormal	heterochromatin	assembly	
Maintenance of the heterochromatic structure of telomeres is important for telomere 
length homoeostasis [56, 172]. A common feature in fibroblasts from HGPS patients and from old 
individuals expressing progerin is the global alteration of histone marks characteristic of 
constitutive heterochromatin [173, 174], however the effect on telomeres is unknown. To 
investigate whether loss of A-type lamins affects the assembly of telomeric heterochromatin, we 
carried out ChIP assays using antibodies recognizing well-established heterochromatic marks, 
H3K9me3 and H4K20me3. Although we found no changes in H3K9me3 levels, we observed a 
significant decrease in telomeric H4K20me3 levels in Lmna-/- MEFs (Figure 8A). Interestingly, 
these defects were phenocopied by pericentric heterochromatin (Figure 8B), supporting the idea 
that alterations of A-type lamins function affect the epigenetic status of constitutive 
heterochromatin [174]. Notably, the changes reported here are different from those described in 
HGPS cells, indicating different functional implications of mutation or silencing of the LMNA gene. 
The epigenetic defects of Lmna-/- MEFs were confirmed by western blot analysis, which showed a 
marked reduction in global H4K20me3 levels but no changes in H3K9me3 (Figure 8C). 
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Next, we evaluated the presence of genomic instability in Lmna-/- cells. We determined 
the frequency of loss of telomeric signals (signal-free ends), chromosome/ chromatid breaks and 
end-to-end fusions, as well as the presence of aneuploidy in pre-senescent Lmna+/+ and Lmna-/- 
MEFs (Figure 9). We found a threefold increase in the number of signal-free ends (Figure 9A) 
and a twofold increase in chromosome and chromatid breaks (Figure 9B) in Lmna-/- MEFs, 
indicating increased genomic instability. This finding was supported by an increased number of 
nuclei with basal DNA damage, as indicated by a twofold increase in cells presenting γ-H2AX-
labeled foci upon loss of A-type lamins (Figure 9C).  
 
In normal cells, inappropriate recombination between telomeres of sister chromatids can 
serve to lengthen one telomere at the expense of another [175]. To test whether aberrant 
recombination involving telomeric repeats contributed to the loss of telomere signals in Lmna-/- 
MEFs, we carried out chromosome orientation fluorescence in situ hybridization (CO-FISH) [175]. 
This technique allows the differential labeling of leading and lagging strands of telomeres. In the 
absence of recombination events between telomeric sequences, only one telomere at each 
chromosome end is labeled with either the leading or the lagging strand probe. If recombination 
occurs, the labeling is split between both sister telomeres, giving rise to telomeres labeled with 
both the leading and lagging strand probes. CO-FISH results indicated that loss of A-type lamins 
did not lead to increased telomeric recombination events [170]. Thus, alternative mechanisms are 
responsible for the loss of telomere signals upon loss of A-type lamins.  
 
In addition to telomeric instability, karyotype analysis showed an increase in the numbers 
of cells with abnormal chromosome dosage in Lmna-/- MEFs (Figure 9D). Since earlier studies 
had shown that reduced Rb family function leads to aneuploidy partly due to defects in 
centrosome duplication [176], we tested if loss of A-type lamins was leading to errors in 
centrosome duplication. This was done by quantifying the centrosome numbers in Lmna+/+ and 
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Understanding the cellular functions of A-type lamins is a highly topical subject because 
of their implication in a number of disease states, including laminopathies, aging and cancer. In 
particular, reduced expression of A-type lamins is emerging as a factor contributing to 
tumorigenesis [14, 15, 162]. Our results indicate that A-type lamins play a fundamental role in the 
maintenance of telomeres and genomic stability. We have shown that loss of A-type lamins leads 
to a variety of alterations in telomere biology: (i) nuclear decompartmentalization of telomeres, (ii) 
impaired maintenance of telomere length homoeostasis, and (iii) defects in telomere chromatin 
architecture. In addition, we found that loss of A-type lamins resulted in an increase in basal 
levels of DNA damage (γ-H2AX foci), increased frequency of chromosome and chromatid breaks, 
and aneuploidy. Given that alterations of telomere biology  is one of the hallmarks of cancer and 
aging, we suspect that the observed alterations upon loss of A-type lamins are contributing to the 
pathogenesis of lamin-related diseases, especially premature aging syndromes such as HGPS 
and tumoral processes characterized by the silencing of the LMNA gene. 
 
Various lines of evidence indicate that the nucleus is compartmentalized and that 
changes in the spatial organization of chromatin affect nuclear functions [6, 10, 11]. The 
importance of telomere compartmentalization for telomere function has been clearly shown in 
yeast [177]. To date, the mechanisms regulating the nuclear distribution of mammalian telomeres 
remain to be identified. In addition, how the nuclear localization of mammalian telomeres 
influences telomere biology is unknown. Lamins, which are absent in yeast, can bind directly to 
DNA and core histones, which attributes them a major role in tethering chromatin to specific sub-
nuclear compartments [178, 179]. Our results show that A-type lamins associate with telomeres 
and contribute towards their proper nuclear localization.  
 
In normal cells, A-type lamins are highly enriched at the nuclear periphery and are also 
found throughout the nucleoplasm [180]. We thus reasoned that loss of A-type lamins could lead 
to the detachment of telomeres from the nuclear periphery. In contrast, we found that the 
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localization of telomeres shifted towards the nuclear periphery in the absence of A-type lamins. 
This raises the possibility that the nuclear periphery represents a default pathway for telomere 
localization. In this model, A-type lamins would have an active role in the localization of telomeres 
throughout the nucleoplasm in mammalian cells. A recent study showing that alterations of the 
nuclear lamina during senescence are associated with increased aggregation of telomeres at the 
nuclear periphery supports this model [168]. It remains to be investigated whether tumor cells 
with silenced LMNA gene also present alterations in telomere compartmentalization and telomere 
structure, length, and function. These types of studies will provide insights into the mechanisms 
altered upon loss of A-type lamins, which could contribute to tumorigenesis. 
 
The profound impact that loss of A-type lamins has on different aspects of telomere 
biology suggests that the nuclear compartmentalization of telomeres could be fundamental for 
telomere metabolism. Our results do not indicate that changes in telomerase activity, binding of 
the shelterin complex components TRF1/ TRF2, or aberrant recombination are the cause of the 
telomere shortening in Lmna-/- cells. It is possible that the accessibility of telomerase and/or 
activities participating in telomere metabolism is reduced on disruption of the scaffold for nuclear 
organization provided by A-type lamins. Studies aimed at elucidating the impact of loss of A-type 
lamins on telomere replication, and on the binding of other shelterin complex components or DNA 
repair factors to telomeres will be fundamental to understanding the mechanisms behind the 
alterations in telomere biology described here. 
 
In addition to the effect on telomere biology, loss of A-type lamins impacts on other 
molecular mechanisms, such as stabilization of Rb and ING tumor suppressors [148, 181, 182]. 
Alterations in these tumor suppressors could contribute to the telomere phenotypes in Lmna-/- 
MEFs and to the genomic instability that drives cancer and aging. While reduced Rb family 
function is likely to be responsible for histone modifications defects in Lmna-/- cells, we showed 





Along with changes in telomere metabolism, Lmna-/- cells were also characterized by 
increased chromosomal instability as manifested by chromosome and chromatid and chromatid 
breaks, and loss of telomeric signal from chromosomes. These cells also had a higher basal level 
of DNA damage, which we detected as γ-H2AX foci. The increase in signal-free ends was 
particularly interesting because they suggested the presence of deprotected telomeres in the 
Lmna-/- cells. Deprotected telomeres are potent inducers of the DNA damage response and 
undergo processing as DSBs by the non-homologous end-joining (NHEJ) pathway. Processing of 
telomeres by NHEJ results in fusions between telomeres of different chromosomes however 
there was no increase in the frequency of end-to-end fusions in the Lmna-/- cells, indicating 
defective NHEJ in these cells. In the next section we investigate the efficacy of NHEJ in lamins-
deficient cells, and the molecular mechanisms by which loss of A-type lamins could contribute to 















A-type lamins are emerging as regulators of nuclear organization and function. Changes 
in their expression are associated with cancer and mutations are linked to degenerative diseases 
-laminopathies-. Although a correlation exists between alterations in lamins and genomic 
instability, the molecular mechanisms remain largely unknown. In the previous chapter we 
showed that loss of A-type lamins leads to alterations in the homeostasis and nuclear distribution 
of telomeres in mouse cells. Cells lacking A-type lamins had increased genomic instability with 
increased basal DNA damage signaling, chromosome and chromatid breaks, and loss of 
telomeric signal (signal-free ends). Despite the presence of signal-free ends, lamins-deficient 
cells did not exhibit any changes in the frequency of chromosome end-to-end fusions, suggesting 
an inhibition of the non-homologous end-joining (NHEJ) pathway. Here, we determined if A-type 
lamins are required for efficient NHEJ of DNA double-strand breaks (DSBs) using deprotected 
telomeres as a model of long-range DSBs, and ionizing radiation-induced breaks as a model of 
short range DSBs. Strikingly, we find that loss of A-type lamins significantly inhibits NHEJ of both 
types of DSBs. We demonstrate that the mechanism behind deficient NHEJ is degradation of 
53BP1, an important NHEJ protein. Importantly, reconstitution of 53BP1 in lamins-deficient cells 
is sufficient to rescue both long-range and short-range NHEJ. These findings are significant as 
they uncover previously unknown mechanisms by which A-type lamins contribute to genomic 
stability and offer new avenues for development of therapy for laminopathies and cancer. 
2.1	Suppression	of	long‐range	NHEJ	in	lamin	A/C‐deficient	cells	
First, we artificially induced telomere deprotection by expression of a dominant negative 
telomere binding protein, TRF2∆B∆M, by retroviral transduction of Lmna+/+ and Lmna-/- MEFs. 
Expression of TRF2∆B∆M has been established to induce telomere dysfunction, which leads to 
chromosome end-to-end fusions in the presence of an intact NHEJ repair pathway [50, 184] 
(Figure 10). NHEJ processing of deprotected telomeres leads to the recruitment of DNA repair 
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To gain insight into specific steps of NHEJ that are affected by loss of A-type lamins, we 
tested whether the cellular levels of key components of the DDR pathway were altered in Lmna-/- 
MEFs. First, we monitored the levels γ-H2AX and 53BP1, which have a function in the sensing of 
dysfunctional telomeres. While there was no difference in the level of H2AX in lamins-deficient 
cells, we confirmed our previous observation of increased γ-H2AX in Lmna-/- MEFs, indicating 
increased basal DNA damage upon loss of A-type lamins (Figure 13A). In addition, we observed 
a marked decrease in the levels of 53BP1 in Lmna-/- MEFs when compared with Lmna+/+ cells by 
both western blot and immunofluorescence (Figure 13A). Consistent with the Lmna-/- MEFs, acute 
depletion of A-type lamins in U2OS cells by shRNAs also led to a significant decrease in 53BP1 
protein (Figure 13B). Importantly, reconstitution of either lamin A, lamin C, or both lamin A and 
lamin C into lamins depleted cells rescued the levels of 53BP1 (Figure 13C).  
 
To determine if other DDR proteins were affected by loss of A-type lamins, we monitored 
the levels of a variety of proteins with different roles in the DDR pathway and in DNA repair in 
lamins-deficient cells. Unlike 53BP1, we detected no significant differences in the cellular levels of 
MDC1, ATM, DNA-PK, Mre11, Nbs1, Ku70, and ERCC1 (Figure 13D). In addition, we found no 
differences in the global levels of TRF1, TRF2, and POT1— proteins with a key structural function 
in telomeres (data not shown), which suggested that the defect in telomeric NHEJ is not likely to 
be due to differences in the shelterin complex at the telomeres. These results indicate that 
depletion of A-type lamins preferentially affects 53BP1 levels.  
 
To investigate if the regulation of 53BP1 was occurring at the transcriptional level we 
monitored the levels of 53BP1 transcripts by real-time quantitative PCR (Q-PCR). As shown in 
Figure 14A, no differences in the levels of 53BP1 transcripts were detected between the two 
genotypes, which suggested that A-type lamins were involved in regulating 53BP1 protein 
stability. Interestingly, incubation of Lmna+/+ and Lmna-/- MEFs with the proteasome inhibitor 
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To determine the contribution of 53BP1-deficiency to the NHEJ defect in lamins deficient 
cells we performed 53BP1 rescue experiments in human cells. U2OS cells were retrovirally 
transduced with 53BP1 or an empty vector (EV) control followed by lentiviral transduction with a 
shRNA specific for depletion of A-type lamins (shLmna) or a shRNA control (shCtrl) (Figure 15A). 
Next, we retrovirally transduced cells with a dominant negative of the telomere binding protein 
TRF2 (TRF2∆B∆M) to induce telomere deprotection. To quantify the resulting end-to-end fusions, 
we scored metaphases based on four different categories of increasing chromosome fusions 
ranging from “less than 5 chromosomes fused” (category 1) to “more than half of the 
chromosomes fused” (category 4) (Figure 15B and C). In cells that express A-type lamins and 
have normal levels of endogenous 53BP1 (EV/shCtrl/TRF2∆B∆M), 53% of metaphases were 
scored in category 1 and 31% in category 4 (Figure 15D). In contrast, lamin A/C-depleted cells 
(EV/shLmna/TRF2∆B∆M) exhibited an overall decrease in the extent of end-to-end fusions (66% 
category 1 and only 14% category 4). Most importantly, reconstitution of 53BP1 into lamin A/C-
depleted cells (53BP1/shLmna/TRF2∆B∆M) resulted in a rescue of chromosome fusions (36% 
category 1 and 40% category 4). As a control, we monitored fusions in cells transduced with an 
empty vector instead of TRF2∆B∆M (53BP1/shLmna/EV). As expected, 100% of metaphases 
belong to category 1, indicating that 53BP1 expression itself does not induce fusions (data not 
shown). We conclude that the effect of A-type lamins in NHEJ of dysfunctional telomeres is due 
to their ability to stabilize 53BP1 protein. 
 
Cathepsin L (CTSL), a cysteine protease which is upregulated upon loss of A-type 
lamins, was demonstrated by our group to participate in degradation of 53BP1 in lamins-deficient 
cells [187]. CTSL is a cysteine protease from the papain family that is ubiquitously expressed in 
mouse and human tissues. Like other proteases, it is synthesized as a zymogen which 
undergoes autoproteolytic processing within the lysosomal/endosomal compartment to release 
the mature active form [188]. Though its activity is enhanced by low pH in the lysosome, CTSL 








































































































less acidic or even neutral environments [189]. CTSL can be secreted to the extracellular matrix 
where it is known to degrade some of its components under physiological conditions –i.e. favoring 
bone resorption in osteoclasts [189]. Increased extracellular CTSL has been reported in 
numerous types of cancer and is often associated with increased invasiveness and metastasis 
[190-192]. More recently, CTSL was found inside the nucleus, where in a more regulated fashion 
it processes specific nuclear components such as histone H3 tails during stem cell differentiation 
and the transcription factor CDP/Cux during cell cycle progression [193, 194].  
 
Previous studies demonstrated that 1,25(OH)2D3 (vitamin D) inhibits CTSL activity in 
colon cancer cells [195, 196]. Interestingly, treatment of lamin A/C-deficient cells with vitamin D is 
sufficient to inhibit activity of CTSL activity and results in increased levels of endogenous 53BP1 
[187]. To determine if restoration of endogenous 53BP1 was sufficient to rescue TRF2∆B∆M 
induced telomere fusions we treated lamins-deficient cells with vitamin D and scored telomere 
fusions (Figure 16). Wild-type MEFs with either a control shRNA (shGFP) or shRNA targeting A-
type lamins (shLmna) were retrovirally transduced with TRF2∆B∆M or an empty vector control. 
Cells were treated vitamin D or with a vehicle control (bovine growth serum, BGS) for 24hours 
prior to collecting metaphases for analysis of telomere fusions by FISH. As expected, treatment of 
shGFP cells with vitamin D had no effect on 53BP1 levels while similar treatment of shLmna cells 
led to a significant increase in levels of 53BP1 (Figure 16A). Consistent with our previous 
findings, the frequency of TRF2∆B∆M -induced fusions in shGFP cells treated with BGS was ~40% 
while the shLmna cells of the same treatment had fusions in less than 10% of the metaphases 
(Figure 16B and C). Remarkably, treatment of shLmna/TRF2∆B∆M cells with vitamin D was 
sufficient to increase the frequency of fusions to ~30%. Along with our overexpression data, these 
results provide conclusive evidence that A-type lamins mediate NHEJ processing of deprotected 































































































































By investigating the role of A-type lamins in NHEJ of deprotected telomeres, we revealed 
a novel pathway that might be affected by laminopathic mutations and/or alterations in the 
expression of A-type lamins. However, despite their tremendous usefulness as models of long-
range DSBs, deprotected telomeres are significantly different from the intrachromosomal breaks 
that might arise due to genotoxic insult to the cell. Telomeric DNA consists of TG-rich repeats, is 
highly heterochromatinized, bound by a distinct group of sequence/structure specific proteins 
(shelterin complex), and adopts a very specific tertiary structure. In fact, specific components of 
the shelterin complex strongly affect recognition of telomeres by the DSB repair pathway and the 
specific mechanism used to process them. Although many of the processes that contribute to 
repair of normal intrachromosomal DSBs are also necessary for processing of deprotected 
telomeres, repair of deprotected telomeres involves additional steps, such as maneuvering of the 
shelterin complex to provide access to DDR proteins. As such, our findings on A-type lamins and 
telomeric NHEJ could not automatically be extrapolated to repair of other forms of DSBs. To 
develop a more inclusive understanding of DSB repair in lamins-deficient cells we investigated 
the global repair of DSBs, which we induced by treating asynchronous cells with ionizing 
radiation. 
 
One of the earliest responses to DNA DSBs is phosphorylation of H2AX (γ-H2AX) in the 
surrounding chromatin [197, 198] followed by recruitment of 53BP1 to the demarcated site [199]. 
These changes occur within minutes of exposure to IR and can be visualized as foci by 
immunofluorescence. IR-induced foci (IRIF) are highly organized structures and are strictly 
regulated during the course of the DNA damage response [200]. Changes in the kinetics of 
formation and resolution of DNA repair foci are used as an indication of alterations in the DDR 
pathway [69]. Here, we tested whether loss of A-type lamins alters the cellular response to IR by 
evaluating the formation/resolution of γ-H2AX and 53BP1 IRIF.  Lmna+/+ and Lmna-/- MEFs were 
treated with 0.5 Gy of IR and immunofluorescence assays performed to label γ-H2AX and 53BP1 













































































































damage while the Lmna-/- cells still exhibited residual γ-H2AX IRIF, which indicated an incomplete 
response to the DNA damage. Given the decreased 53BP1 in lamin A/C-deficient cells, we 
determined if the kinetics of 53BP1 IRIF was altered in the Lmna-/- and Lmna+/+ cells. As with γ-
H2AX IRIF, nearly 100% of the cells in both genotypes responded to IR by forming 53BP1-
labeled foci, and the overall kinetics of formation and resolution of 53BP1 DNA repair foci was 
similar in both genotypes (Figure 17B).  
 
While the ability of cells to form 53BP1 IRIF was unaffected by the absence of A-type 
lamins, we observed a profound and consistent decrease in the intensity of fluorescence of 
53BP1 IRIF in Lmna-/- MEFs with respect to Lmna+/+ controls at all times post-IR (Figure 18 and 
data not shown). Striking differences in intensity were observed at 30 min, 1 h, and 2h after IR. 
By 24 h, 53BP1 protein was dispersed throughout the nucleus in Lmna+/+ cells, mirroring the 
localization of the protein in cells that were not irradiated. In contrast, Lmna-/- fibroblasts still 
displayed decreased 53BP1 intensity, and there were changes in its nuclear distribution so that 
rather than having a disperse distribution, it had accumulated in a few large foci. Since the 
intensity of labeling with γ-H2AX foci was indistinguishable between Lmna+/+ and Lmna-/- cells 
throughout the time course of the experiments, we conclude that the difference in 53BP1 
accumulation in Lmna-/- cells is specific to that protein and not due to widespread changes in the 
DDR proteins. 
 
Large 53BP1 nuclear bodies, similar to what we observed, were recently shown to 
colocalize with OPT (Oct-1, PTF, transcription) domains in G1 BJ fibroblasts [201]. These 53BP1-
OPT domains were characterized by low levels of transcriptional activity and co-localized with γ-
H2AX and MDC1. The authors proposed that the 53BP1-OPT bodies mark damaged DNA, 
particularly fragile chromosome sites, where replication is incomplete. In support of this model, 
treatment of cells with low levels of aphidicolin, which induces DNA damage at fragile sites [202], 
but not hydroxyurea increased the formation of 53BP1-OPT bodies. Future studies will determine 
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To determine the functional significance of decreased 53BP1 at IRIF in Lmna-/- cells, we 
evaluated repair of IR-induced DSBs by performing neutral comet assays. Asynchronously 
growing Lmna+/+ and Lmna-/- MEFs were treated with 8 Gy of IR, cells were collected at different 
times post-IR, and the extent of DNA DSB repair evaluated by single cell gel electrophoresis 
under neutral conditions [203]. Single cell gel electrophoresis results in a comet-shaped 
distribution of DNA as fragments migrate away from the center of the nucleus. The comet head 
contains high-molecular weight and intact DNA, and the comet tail contains the leading ends of 
migrating fragments (Figure 20a). Olive moment, a quantification of the amount of DNA and its 
distribution in the tail, is a measure of unrepaired DNA breaks [203]. When compared to wild-type 
MEFs, lamin A/C-deficient cells had a higher olive moment at all times tested post-IR (Figure 
20b). This indicated that DNA DSB repair was substantially compromised by loss of A-type 
lamins.  
 
The repair of DSBs after IR usually follows bimodal kinetics with fast and slow repair 
phases [69]. There is substantial evidence implicating classical NHEJ as the major mechanism 
used during the fast phase of DSBs repair, and alternative NHEJ or HR in the slow phase of 
repair [204, 205]. This bimodal form of DNA DSBs repair is clearly observed in Lmna+/+ 
fibroblasts, such that the fast phase occurred within 60 minutes post-IR, followed by a relatively 
slow phase of DSBs repair onwards (Figure 20B). However, Lmna-/- fibroblasts did not display this 
fast phase of repair, requiring up to 150 minutes to repair the damage that could be repaired 
within 30 - 60 minutes by the wild-type cells (Figure 20B). This indicated that the involvement of 
A-type lamins in NHEJ extends beyond the scope of deprotected telomeres, being also applicable 
to the repair of IR-induced DSBs. 
 
To determine if 53BP1 could rescue the defective fast-phase of repair of IR-induced 
DSBs in Lmna-/- MEFs, cells were retrovirally transduced with a 53BP1 construct or an empty 
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Interpretation of these results is complicated by the fact that previous reports have 
indicated dispensability of 53BP1 for repair of short-range DNA DSBs, along with our data 
showing that depletion of 53BP1 in wild-type MEFs did not inhibit the fast-phase of repair (Figure 
21C). We reason that 53BP1 deficiency in lamin A/C-deficient cells is not solely responsible for 
the observed defects in the fast-phase of repair. Rather, it is the combined deficiency of A-type 
lamins and 53BP1 which is responsible for the shift in the kinetics of DNA DSBs repair towards a 
slower operating mechanism. This slower form of repair could represent a lower efficiency of C-
NHEJ or activation of an alternative mechanism of repair in lamins-deficient cells. In either case 
the fact that reconstitution of 53BP1 restores normal kinetics of repair of IR-induced DNA DSBs 
supports a role for 53BP1 in promoting C-NHEJ repair and inhibiting alternative mechanisms of 
DNA DSBs repair. 
2.6	DISCUSSION	
Previous studies had shown that expression of mutant lamin A isoforms leads to alterations in the 
DDR and defective repair, which translate into increased sensitivity to DNA-damaging agents 
[152, 173, 206]. Prior to our studies the effect of complete loss of A-type lamins on DNA repair 
mechanisms remained unknown. By demonstrating that TRF2∆B∆M -induced telomere fusions 
require A-type lamins, we provided the first link between loss of A-type lamins and defective 
NHEJ repair. The fact that mutations in the LMNA gene were previously associated with 
increased NHEJ [152] indicates yet another functional difference between mutation and loss of A-
type lamins. In light of a report showing that loss of 53BP1 inhibits processing of dysfunctional 
telomeres by NHEJ [51], we hypothesized that destabilization of this protein in lamins-deficient 
cells was in part responsible for the observed phenotype. In support of this hypothesis, our 
reconstitution experiments clearly demonstrate that destabilization of 53BP1 upon loss of A-type 
lamins is responsible for the defects in the processing of dysfunctional telomeres by NHEJ. 
Interestingly, the telomeric NHEJ elicited by TRF2∆B∆M requires 53BP1 and DNA ligase IV, 



















































































































In addition to the role of A-type lamins in long-range NHEJ, our studies demonstrate their 
participation in short-range DSBs repair, as exemplified by the defects in the fast-phase of repair 
of IR-induced DSBs. In mammalian cells DNA DSB repair occurs mainly by NHEJ and HR. NHEJ 
is faster and more efficient than HR, but at the expense of low fidelity. Analysis of kinetics of 
repair of IR-induced DNA DSBs has revealed two types of NHEJ. C-NHEJ represents the fast 
component of DSB rejoining and relies on DNA-PK and the XRCC4/DNA Ligase IV complex [205, 
208]. Although DNA-PK deficiency retards repair of DNA DSBs, damage is eventually repaired by 
a slower operating mechanism, possibly A-NHEJ [204]. Given the dominance of the slow phase 
repair in lamins-deficient cells we speculate that it might represent an upregulation of A-NHEJ in 
lieu of decreased C-NHEJ. Interestingly reconstitution of 53BP1 in lamins-deficient cells was 
sufficient to rescue the fast-phase repair of IR-induced DNA damage. While a whole body of 
evidence indicates that 53BP1 participates in long-range DNA end-joining processes, such as 
class switch recombination, V(D)J recombination, and chromosome end-to-end fusions, the role 
of 53BP1 in short-range DSB repair is not clear [99]. Depletion of 53BP1 from wild-type cells 
resulted in no change in their ability to complete the fast-phase of repair IR-induced DSBs. The 
fact that 53BP1 was able to rescue fast-phase repair in Lmna-/- cells suggests that the role of 
53BP1 in repair of IR-induced DSBs in wild-type cells is masked by a functional redundancy, 
which is lost in A-type lamins-deficient cells. We speculate that loss of A-type lamins activates 
compensatory mechanisms that repair DSBs with slower kinetics. Restoration of 53BP1 in this 
context would then alter the balance between different DSBs repair pathways, tilting it in favor of 
the fast-phase C-NHEJ. Future studies will address whether loss of A-type lamins is associated 
with upregulation of other repair pathways, such as A-NHEJ.  
 
Given the well established contribution of genomic instability to aging and cancer, 
identifying the molecular mechanisms involved in maintaining genomic integrity is of utmost 
importance. DNA DSBs repair, which occurs mainly by NHEJ and HR, is critical for maintaining 
genomic stability. We have demonstrated that the structural nuclear proteins A-type lamins 




by NHEJ. We also provide evidence that the mechanism which allows A-type lamins to promote 
long-range (dysfunctional telomeres) and short-range (IR-induced DNA DSBs) classical-NHEJ is 
















In the previous chapters, we demonstrated a significant inhibition of the non-homologous 
end-joining (NHEJ) pathway in lamins-deficient human and mouse cells. Lamins-deficient cells 
exhibit decreased levels of 53BP1, an important NHEJ protein, due to post-translational 
degradation. Increasing the levels of 53BP1 in lamins-deficient cells by exogenous expression or 
inhibiting the degradation of the endogenous protein was sufficient to rescue NHEJ. To attain a 
more complete understanding of how A-type lamins affect repair of DNA double strand breaks, 
we investigated whether A-type lamins could affect homologous recombination (HR). Based on 
the idea that different DSB repair pathways compete for repair substrate and recent reports 
showing that 53BP1 is a potent inhibitor of HR, we hypothesized that decreased 53BP1 in lamin 
A/C-depleted cells would lead to increased HR. Surprisingly, we find that depletion of lamins 
significantly compromises HR by a mechanism involving transcriptional downregulation of BRCA1 
and RAD51. Furthermore, we show that repression of BRCA1 and RAD51 requires p130, and 
occurs in the context of decreased Rb and p107 protein levels. It was previously established that 
loss of A-type lamins leads to proteasomal degradation of Rb and p107; however the exact 
mechanism by which they become targeted for degradation remained an enigma. We provide 
evidence that the cysteine protease Cathepsin L, which is upregulated in lamins-deficient cells 
contributes to degradation of Rb and p107. In line with the DNA repair defects, lamins-deficient 
cells exhibit increased radiosensitivity. This study demonstrates that A-type lamins promote 
genomic stability by maintaining the levels of proteins with key roles in DNA DSBs repair by 
NHEJ and HR, and reveals an unprecedented role for Cathepsin L in regulating Rb and p107.  
3.1	Decreased	HR	in	lamins‐deficient	cells	
To evaluate the proficiency of HR in lamins-deficient cells, we used a chromosomally 
integrated reporter substrate, DR-GFP, in MCF-7 cells that were depleted of A-type lamins [209]. 
The DR-GFP substrate consists of two tandem GFP sequences that have both been mutated to 
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To elucidate the molecular mechanisms behind HR defects in lamins-deficient cells, we 
monitored recruitment of RAD51, an essential HR protein, to IRIF. We treated lamin A/C 
proficient and deficient MCF-7 DR-GFP cells with 8 Gy of IR and performed immunofluorescence 
to detect RAD51 foci 6 h post-IR. We found a significant decrease in the formation of RAD51 foci, 
such that only 27% of shLmna cells scored positive for RAD51 IRIF, as opposed to 64% of the 
shCtrl cells (Figure 23A and C). To ensure that our results were not cell type- or shRNA 
sequence-specific, we performed acute depletion of A-type lamins in wild-type MEFs, using a 
mouse-specific shRNA. Consistently, loss of A-type lamins led to a decrease in the formation of 
RAD51 IRIF (Figure 23B). Next, we determined if upstream steps in the HR pathway were 
affected by monitoring the formation of RPA IRIF. RPA binds to single stranded DNA (ssDNA), 
which is formed during end-resection in homologous recombination, and can also be visualized 
as foci by immunofluorescence staining. The presence of RPA foci is generally considered an 
indication of successful DNA end-resection. As with the RAD51 IRIF we found a significant 
reduction in the formation of RPA IRIF in the lamins-depleted cells (Figure 23D). 
 
Interestingly, monitoring the levels of RAD51 by western blot revealed a marked 
decrease of the protein in lamins-depleted cells. (Figure 24A). In contrast, global levels of RPA 
were not affected by depletion of A-type lamins (Figure 24B). This indicated that another critical 
upstream step in the HR process was affected. Since the formation of RPA foci reflects the 
presence of ssDNA, we reasoned that DNA end-resection could be affected by loss of A-type 
lamins. Based on the importance of BRCA1 in the formation of ssDNA we investigated whether 
BRCA1 protein levels were also being affected by depletion of A-type lamins. We were surprised 
to find that like RAD51, depletion of A-type lamins from MCF-7 cells was associated with a 
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To test our model we overexpressed CTSL in wild-type MEFs and monitored the levels of Rb 
family members and RAD51. Indeed, we found that upregulation of CTSL was associated with a 
substantial decrease in pRb and p107 but little effect on p130, mirroring the phenotype observed 
in lamins-deficient cells ( 
Figure 28). These results demonstrate a novel role for CTSL in the regulation of the Rb family of 
tumor suppressors. However, altering the levels of these proteins was not sufficient to induce 
transcriptional repression of BRCA1 or RAD51 (data not shown), suggesting that A-type lamins 
have additional roles in the regulation of transcription of these genes. 
3.5	Loss	of	A‐type	lamins	increases	radiosensitivity	
Radiation therapy is a common modality in the treatment of cancer. IR preferentially kills repair-
compromised cells, which are unable to deal with the extensive DNA damage generated. To 
determine if loss of A-type lamins and the associated deficiency in 53BP1 and RAD51/BRCA1 
affect sensitivity to IR, we performed colony formation assays. Lmna+/+ and Lmna-/- MEFs were 
treated with increasing doses of IR up to 6 Gy, and their clonogenic capability assessed after 10 
days in culture. The survival curves shown in (Figure 29) describe the relationship between the 
radiation dose and the proportion of cells that retain reproductive integrity. In line with severely 








We have shown that acute loss of A-type lamins leads to a severe compromise in HR. 
These studies reveal an unprecedented role for A-type lamins in the transcriptional co-regulation 
of two key factors in HR, RAD51 and BRCA1, by means of formation of p130/E2F4 repressor 
complexes. Since BRCA1 associates with the MRN complex, which displays nucleolytic activity, it 
is likely that HR-dependent end-resection itself is afflicted in lamins-deficient cells. This notion is 
consistent with the defective recruitment of RPA to DNA DSBs in the absence of detectable 
changes in the global levels of the protein. HR requires nucleolytic degradation of DNA ends to 
generate 3’-ended ssDNA, a process mediated by MRN, CtIP and BRCA1 proteins. The ssDNA 
generated by end-resection is rapidly bound by Replication Protein A (RPA), which removes 
secondary structures in ssDNA and allows the formation of the RAD51 nucleoprotein filament that 
drives DNA strand invasion and exchanges during HR [213]. BRCA1 also interacts with 
phosphorylated CtIP, a protein that is involved in DNA end-resection and known to function in 
Figure 29 Lmna-/- MEFs display increased sensitivity to 
ionizing radiation. Clonogenic survival in Lmna+/+ and 
Lmna-/- MEFs in response to increasing doses of 
radiation (0 to 6 Gy). Shown are the surviving fractions 





















both HR and A-NHEJ [77, 81, 86, 214, 215]. Disrupting the interaction of BRCA1 with CtIP is 
detrimental to HR, but does not affect A-NHEJ [215]. Thus, consistent with our discussion of C- 
versus A-NHEJ in lamin A/C deficient cells it is possible that loss of BRCA1 and RAD51 inhibits 
HR, but does not affect the ability of cells to enact A-NHEJ. Overall, our data indicate a that A-
type lamins promote the major mechanisms of DNA repair by contributing to the stability of 
53BP1 protein and transcription of BRCA1/RAD51 genes. Unravelling which mutations in A-type 
lamins affect levels of CTSL, destabilize 53BP1 and Rb family members and/or transcriptionally 
regulate RAD51/BRCA1 will allow us to predict which lamins-related diseases present with 
defects in specific mechanisms of DNA repair. The connection between CTSL and cellular levels 
of Rb and p107 is particularly interesting since upregulation of CTSL has been associated with a 
number of cancers. It will be useful to determine if CTSL plays a role in regulation of Rb/p107 
under normal physiological conditions, and elucidate the exact mechanism by which upregulation 
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In chapter two, I focus on the role of A-type lamins in non-homologous end-joining (NHEJ), 
showing that A-type lamins are necessary for both long- and short-range NHEJ. I demonstrate 
that the mechanism by which loss A-type lamins inhibits NHEJ is via destabilization of 53BP1. In 
chapter three, I show that loss of A-type lamins leads to inhibition of homologous recombination 
(HR) of DSBs due to transcriptional repression of BRCA1 and RAD51 by the 130/E2F4 complex. 
Importantly, these studies led to our discovery of novel roles for the cysteine protease CTSL in 
regulating the stability of both 53BP1 [187] and the retinoblastoma pocket family proteins. The 





Telomeres are nucleoprotein structures that protect the ends of eukaryotic chromosomes 
[216-218].  A minimal length of telomeric DNA repeats and proper binding of specialized proteins 
such as shelterin complex components and DNA repair factors are required for the maintenance 
of telomere structure and function [40]. Similarly, acquisition of a heterochromatic structure at 
mammalian telomeres is critical for the control of telomere homeostasis [219]. The importance of 
telomere compartmentalization for telomere function has been clearly demonstrated in yeast 
[177]. In Saccharomyces cerevisiae or budding yeast, telomeres are clustered in foci at the 
nuclear periphery [220, 221]. At least two redundant mechanisms have been identified that 
mediate tethering of telomeres to the periphery. One mechanism involves yKu70/Ku80 
heterodimer, which associates with the telomerase complex Est1/Est2/Tlc1, and an integral inner 
nuclear membrane protein of the SUN domain family, Mps3 [222, 223].  A second mechanism 
involves the histone deacetylase Sir4, which binds to the inner nuclear membrane-associated 
protein Esc1 (Enhancer of silent chromatin 1) [224-226]. Importantly, disruption of the tethering of 
telomeres to the nuclear periphery leads to deprotection and hyper-recombination of telomeres 
[223], and derepression of subtelomeric genes [177].  In the case of Sir4, inactivating mutations 
also involve telomere shortening [227], suggesting a link between telomere localization at the 
nuclear periphery and maintenance of length homeostasis. 
 
Mammalian telomeres do not accumulate at the nuclear periphery, except during meiosis 
[228]. They are distributed throughout the entire nucleoplasm in G1 and S phases of the cell 
cycle, while assembling in the center of the nucleus during G2 in preparation for mitosis [166]. It 
has been proposed that interactions between telomeres and the nuclear matrix determine their 




telomeres in a broad time range has provided new information about telomere dynamics within 
the nucleus.  At short time scales, the diffusion of telomeres is anomalous, while at longer time 
scales a normal diffusion is observed with a wide distribution of diffusion constants. This transient 
anomalous diffusion was explained by the existence of a local binding or obstruction mechanism 
to telomere mobility [231]. To date, the molecular mechanisms that orchestrate nuclear tethering 
and localization of mammalian telomeres, and their relevance for telomere metabolism remain 
unknown [232]. 
 
Interestingly, the 3D organization of telomeres is altered in tumor cells [166, 167], and in 
senescent cells that present defects in the nuclear lamina [168].  This data suggests a 
relationship between changes in nuclear distribution of telomeres and the alterations of telomere 
metabolism observed during senescence and immortality. We have shown that A-type lamins 
bind to mouse telomeres and participate in their nuclear compartmentalization. Embryonic 
fibroblasts from LMNA null mice exhibit changes in the nuclear distribution of telomeres towards 
the nuclear periphery and away from the nuclear center. This was unexpected, since lamins are 
highly enriched at the nuclear periphery. However, while B-type lamins are exclusively found at 
the nuclear periphery, lamins A and C are proposed to form part of a filamentous meshwork that 
expands throughout the entire nucleoplasm.  We speculate that A-type lamins actively participate 
in the distribution of telomeres throughout the nucleus. In the absence of A-type lamins, proteins 
at the nuclear periphery such as B-type lamins, inner nuclear membrane proteins or nuclear pore 
complex proteins, could undertake the tethering of telomeres. In this model, the nuclear periphery 
would represent a default pathway for telomere distribution, which would resemble telomere 
localization in yeast, which do not express lamins. This model is supported by a 2010 study in 
which Winnok H. De Vos and colleagues demonstrated hypermobility of telomeres in human 
fibroblasts that lack expression of lamin A/C. This study supports the idea that A-type lamins help 





Further studies need to characterize the molecular determinants of the association of A-
type lamins with telomeres. A-type lamins can bind directly to DNA-chromatin and indirectly via 
their interaction with lamin-associated proteins such as LAP-2α, emerin and MAN1 [12, 233]. 
Although we found that A-type lamins bind telomeric sequences by chromatin 
immunoprecipitation, we do not know whether the interaction is direct or mediated by lamin-
associated proteins. LAP-2α is of special interest given that it binds to telomeres during nuclear 
reassembly after mitosis [234]. In addition, LAP-2α mediates the interaction of Rb with A-type 
lamins, contributing to the stabilization of Rb family function [235], and is the only member of its 
family that is localized throughout the nucleoplasm. All these characteristics make LAP-2α a good 
candidate for mediating tethering of telomeres to A-type lamins. From the telomere end, it is 
possible that components of the shelterin complex associate with A-type lamins or lamin-
associated proteins localized at the nucleoplasm. Alternatively, A-type lamins might recognize 
heterochromatic features at the telomere. Heterochromatin Protein 1 (HP1) has been shown to 
form a complex with A-type lamins and LAP-2α [236], and therefore could participate in the 
tethering of heterochromatic domains such as telomeres and centromeres to the scaffold of A-
type lamins. 
4.2	A‐type	lamins	and	telomere	structure,	length	and	function	
The first evidence supporting a role for A-type lamins in telomere biology came from 
studies of patients with Hutchinson Gilford Progeria Syndrome. HGPS or progeria is a premature 
aging disease caused by a mutation in the LMNA gene that generates a truncated lamin A 
isoform known as progerin, which is toxic for the cell [140, 155]. HGPS fibroblasts were shown to 
undergo faster telomere attrition during proliferation than normal counterparts [22, 141]. 
Fibroblasts from HGPS patients and aged individuals also present defects in epigenetic marks 
characteristic of constitutive heterochromatin, although the effect on telomeres was not tested 
[173, 174].  The mechanism by which mutation in the LMNA gene resulting in the expression of 




between A-type lamins and telomeres was provided by studies showing that telomerase rescues 
proliferative defects of human fibroblasts expressing lamin A mutants [237], and that senescence-
associated alterations of the nuclear lamina are accompanied by aggregation of telomeres to the 
nuclear lamina [168].  
 
Despite the importance of telomere maintenance for cancer progression, the impact that 
the loss of A-type lamins that characterizes certain tumor types has on telomere biology remained 
undetermined. Our study using LMNA knock-out mouse fibroblasts as a model revealed that A-
type lamins play a key role in the maintenance of telomere structure, length and function.  
Telomeres in Lmna-/- mice are consistently shorter than the corresponding wild-type controls, and 
exhibit an increase in signal-free ends (loss of telomeric signals).  Furthermore, acute depletion of 
A-type lamins by shRNAs specific for depletion of lamins A and C, leads to telomere shortening 
after only a few passages of the cells in culture as determined by Quantitative Fluorescence In 
Situ Hybridization (Q-FISH) with a telomeric probe. Most importantly, reintroduction of either 
lamin A, lamin C, or both by retroviral transduction rescued the telomere shortening phenotype. 
Reintroduction of lamins significantly increased the average telomere length and was associated 
with a decrease in the pool of short telomeres, and an increase in the pool of long telomeres. 
These data indicate that A-type lamins play a key role in the control of telomere length. However, 
we do not know the mechanism behind the telomere shortening phenotype observed in A-type 
lamins-deficient cells. The levels of telomerase activity and the binding of the shelterin complex 
components TRF1 and TRF2 were not affected by the loss of A-type lamins. Similarly, we did not 
observe any evidence of aberrant recombination at telomeres, which could explain the loss of 
telomeric sequences. It is possible that the binding of other shelterin complex components or 
DNA repair factors with a function at the telomere could be defective in LMNA null cells. 
Alternatively or concomitantly, loss of A-type lamins might hinder the accessibility of telomerase 






Maintenance of a heterochromatic structure at telomeres is also critical for the control of 
telomere length. Previous studies demonstrated that loss of heterochromatic features such as 
methylation of histones H3 and H4 at different lysine residues and methylation of subtelomeric 
DNA results in a pronounced telomere elongation phenotype [56, 232, 238, 239]. In most cases, 
telomere elongation correlated with an increase of telomere sister chromatid exchange (T-SCE) 
events, characteristic of the activation of Alternative Lengthening of Telomeres (ALT) pathway of 
telomere maintenance [32, 240].  We found that loss of A-type lamins resulted in decreased 
levels of the heterochromatic mark H4K20me3 -histone H4 trimethylated at lysine 20-. This defect 
is likely due to the fact that Rb family members, which have a known role in the stabilization of 
this chromatin modification, are targeted to degradation by the proteasome upon loss of A-type 
lamins [148]. However, contrary to the telomere elongation phenotype characteristic of Rb-
deficient cells [171, 241] and H4K20me3- deficient cells (Suv4-20h double knock-out) [55], the 
loss of Rb or decrease in H4K20me3 was not sufficient to trigger telomere elongation in the 
context of A-type lamins deficiency.  Thus, A-type lamins, or a process regulated by these 
proteins, are necessary for the elongation of telomeres upon loss of Rb family members and 
decrease of H4K20me3.  Interestingly, depletion of A-type lamins in U2OS cells, an 
osteosarcoma cell line which relies on ALT for telomere maintenance, did not lead to any 
significant alterations in telomeric sister-chromatid exchange, indicating that loss of A-type lamins 
is sufficient to inhibit ALT that is associated with alterations in histone methylation. 
4.3	Mechanisms	of	DNA	DSBs	repair	
Repair of damaged DNA is critical for maintenance of genomic stability. Among the 
various types of DNA damage, DSBs are the most deleterious, leading to mutations, loss of 
genomic material, and translocations if not properly repaired. The two major pathways of DSBs 
repair, homologous recombination (HR) and classic non-homologous end-joining (C-NHEJ) are 
considered to compete for repair substrate [62, 90]. HR is error-free and requires both resection 




ligation of damaged DNA during C-NHEJ requires neither extensive resection nor homologous 
templates. C-NHEJ is a fast and error-prone mechanism which can cause translocations and/or 
loss of genetic material. While C-NHEJ is the predominant repair mechanism in G0/G1 stages of 
the cell cycle, when the lack of the sister chromatid prevents HR from being used, the slower HR 
repair mechanism has traditionally been thought to dominate during S and G2 phases of the cell 
cycle. Recent evidence has challenged the notion of HR dominance in S/G2, suggesting that the 
need for rapid DNA damage repair makes NHEJ the preferred pathway even when HR is possible 
[92]. According to this data it is only when the damage cannot be repaired by NHEJ that end-
resection is promoted and additional mechanisms undertake DNA repair. Besides HR and C-
NHEJ, a less understood pathway, alternative non-homologous end-joining (A-NHEJ), is 
sometimes used as a backup repair pathway [69, 242]. A-NHEJ involves processing of DNA by 
end-resection to reveal regions of microhomology which are then ligated. In contrast to HR, 
resected DNA is not filled in during A-NHEJ, making it a more deleterious process than both C-
NHEJ and HR. In line with this notion, A-NHEJ is associated with high frequencies of 
chromosomal translocations and genomic instability. 
4.4	A‐type	lamins	and	DNA	repair	
Expression of mutant lamin A isoforms is associated with defective DNA repair.  
Fibroblasts from HGPS patients and from a mouse model of progeria generated by depletion of 
the metalloproteinase responsible for the maturation of prelamin A (Zmpste24 knock-out) [152, 
158] have alterations in the DDR.  In particular, these cells exhibit increased DNA damage and 
chromosome aberrations and are more sensitive to DNA-damaging agents.  At a molecular level, 
HGPS and Zmpste24-/- MEFs showed a delayed recruitment of 53BP1 to phosphorylated histone 
H2AX (γ-H2AX)-labeled DNA repair foci upon induction of DNA damage, and a delayed 
disappearance of these foci.  Zmpste24-/- MEFs also showed impaired recruitment of RAD51 to 
sites of DNA damage leading to a delayed checkpoint response and defective DNA repair [152].  




A/C diminished the cellular ability to form γ-H2AX-labeled DNA repair foci in response to mild 
doses of cisplatin or UV irradiation, and mislocalized ATR kinase, a key sensor in DDR [161].  
More recent studies have demonstrated that fibroblasts from HGPS patients and from Zmpste24-/- 
MEFs display an activated DNA damage response, as evidenced by enhanced γ-H2AX, and 
activation of the p53 pathway [160, 173]. All these reports suggest that unprocessed prelamin A 
and truncated lamin A act in a dominant negative fashion to perturb DNA damage response and 
repair.  Elucidating the specific steps of these processes that are affected in the different 
laminopathies could bring about new possibilities for treatment.  
4.5	A‐type	lamins	affect	53BP1‐dependent	NHEJ	of	telomeres	
Our study shows that LMNA null fibroblasts exhibit signs of genomic instability: higher 
incidence of chromosome and chromatid breaks, increased numbers of signal free ends 
(telomere loss), and basal levels of unrepaired DNA, as shown by the presence of cells labeled 
with γ-H2AX. These data indicate that not only mutant forms of lamins, but also depletion of A-
type lamins affects the ability of cells to properly deal with DNA damage. Nevertheless, the 
different mutations and the changes in expression of A-type lamins are expected to have different 
consequences for nuclear function, given the variety of diseases associated with the different 
alterations. Establishing for example, if tumor cells in which the LMNA promoter is silenced by 
DNA methylation are defective in DNA repair and more sensitive to DNA damaging agents, would 
provide valuable information towards the use of lamins as targets for cancer therapeutics.  
 
Loss of telomere integrity activates a classical DDR characterized by the activation of the 
ATM/p53 pathway and the formation of DNA damage foci at telomeres [185]. These telomere 
dysfunction-induced foci (TIF) contain many DNA damage response proteins, including γ-H2AX, 
53BP1, MDC1, and MRN complex, and are established as a read-out of telomere damage. 
Activation of ATM/p53 is followed by the processing of dysfunctional telomeres by the NHEJ 




that deprotected telomeres are more mobile and sample larger territories within the nucleus than 
functional telomeres [51, 243]. Dimitrova et al. presented evidence about 53BP1 playing an active 
role in chromatin dynamics, such that it facilitates the association and fusion of dysfunctional 
telomeres that might be far away within the nucleus [51]. Our study shows that chromosome end-
to-end fusions of dysfunctional telomeres, induced by the expression of a dominant negative 
TRF2 protein, require A-type lamins, providing the first link between loss of A-type lamins and 
defective NHEJ repair.  In addition, we demonstrated that the mechanism of inhibition of telomere 
NHEJ was due to the destabilization of 53BP1 in lamin A/C-deficient cells. It is possible that in 
addition to maintaining 53BP1 stability, A-type lamins play an active role in the DDR and in the 
53BP1-mediated regulation of mobility and NHEJ of dysfunctional telomeres. In 2010 Winnok H. 
De Vos and colleagues demonstrated intranuclear hypermobility of telomeres in human 
fibroblasts that lack expression of lamin A/C [244]. Based on this report, increased mobility of 
telomeres in the Lmna-/- fibroblasts should circumvent the need for 53BP1 for efficient fusion; 
however we still see decreased telomere fusions in these cells, arguing against the 53BP1-
mediated telomere mobility hypothesis. 
4.6	A‐type	lamins	affect	NHEJ	of	ionizing	radiation‐induced	DSBs	
Despite the increase in genomic instability, similar to what was reported in progeria cells, 
loss of A-type lamins does not impair activation of the DNA damage response (DDR) when cells 
are exposed to ionizing radiation. ATM-dependent phosphorylation of H2AX and p53 at Ser15 
was not affected in Lmna-/- mouse embryonic fibroblasts (MEFs), and the kinetics of formation 
and resolution of γ-H2AX ionizing radiation-induced foci (IRIF) was indistinguishable between 
lamins-deficient and –proficient cells In contrast, lamins-deficient cells showed defective 
accumulation of 53BP1 at IRIF at all post-irradiation times tested. Importantly, this deficiency was 
due to the decrease in 53BP1 and not to failed recruitment, since 53BP1 IRIF formed although at 




increased genomic instability and radiosensitivity suggested that the loss of 53BP1 could be 
responsible for the DNA repair deficiencies observed in lamin A/C-deficient cells.  
 
Consistent with our hypothesis, lamins-deficient cells treated with ionizing radiation had 
profound defects in the fast phase of DNA DSBs repair. Fast repair is traditionally associated with 
C-NHEJ, since similar defects are observed upon depletion or mutation of essential factors in this 
process such as DNA-PK, Ku80, XRCC4, and DNA ligase IV. Importantly, we found that 
reconstitution of 53BP1 in lamins-deficient cells rescues the defects in NHEJ of DNA DSBs and 
dysfunctional telomeres. Overall, these results revealed that 53BP1 deficiency is a major 
contributor of the DNA repair phenotype observed in lamins-deficient cells. This is a critical 
observation, since many studies rely on foci formation to determine whether a step in the DDR is 
functional. Our results indicate that it is important to monitor the levels of DDR proteins at DSBs 
when assessing deficiencies in DNA repair. 
4.7	How	are	the	levels	of	53BP1	regulated	by	A‐type	lamins?	
During our exploration of mechanisms by which A-type lamins affect DNA DSBs repair 
our group discovered a role for cathepsin L (CTSL) in the stability of 53BP1 protein. The first link 
between CTSL and A-type lamins was established in a mouse model of progeria [160]. In 
particular, mice lacking Zmpste24, a metalloprotease that participates in the maturation of lamin 
A, exhibit a drastic increase in the levels of CTSL mRNA. Although this suggested a relationship 
between CTSL and the aging phenotype, no association was established between CTSL and the 
increase in genomic instability displayed by these mice. Our studies showed that Lmna-/- cells 
also exhibit a marked increase in the levels of CTSL mRNA and protein [187], indicating that loss 
of A-type lamins induces transcriptional upregulation of CTSL. Furthermore, we show that 
upregulation of CTSL leads to a dramatic downregulation of 53BP1 protein levels. Since many 




suppression of DSBs repair as an important mechanism by which CTSL contributes to 
tumorigenesis. 
4.8	Lamins	role	in	DNA	DSBs	repair	by	HR	
Loss of 53BP1 favors repair of DNA DSBs by HR [89, 90]. However, despite decreased 
53BP1 levels, we found that HR was suppressed upon depletion of A-type lamins. Inhibition of 
HR is explained by the significant reduction in expression of two key factors in this process, 
BRCA1 and RAD51. In contrast to the CTSL-mediated degradation of 53BP1, decreased levels of 
BRCA1 and RAD51 were brought about by transcriptional repression. Previous reports had 
demonstrated transcriptional repression of BRCA1 and RAD51 under certain stressful conditions, 
such as hypoxia or PARP inhibition, via formation of p130/E2F4 complexes at E2F sites within 
their promoters [211, 212]. We found that repression RAD51 and BRCA1 genes in lamins-
deficient cells was linked to the status of members of the Rb family of tumor suppressors (Rb, 
p107 and p130) - repression of BRCA1 and RAD51 required p130 and occurred in the context of 
decreased levels of Rb and p107. Furthermore co-immunoprecipitation studies in cells depleted 
of A-type lamins showed an increase in the formation of p130/E2F4 complexes. These data 
suggest activation of a repressive mechanism in lamins-deficient cells, where altering the balance 
of the pocket proteins favors association of p130 with E2F4, leading to transcriptional inhibition of 
responsive promoters. However, we cannot rule out the possibility that loss of A-type lamins 
leads to alterations in the nuclear localization of BRCA1 and RAD51 genes, which might 
contribute to their transcriptional repression.  
 
It is well established that pocket proteins associate with lamins and that loss of A-type 
lamins leads to increased degradation of Rb and p107 [148]. This is thought to occur partly 
through the ability of A-type lamins to regulate the sub-nuclear localization of these proteins. 
However up until now, the specific mechanism by which Rb and p107 are targeted for 




component of the 19S proteasome subunit which is overexpressed in Lmna KO cells [165]. Given 
our recent findings that CTSL promotes the degradation of 53BP1, we speculated that this 
protease could be the missing link between A-type lamins and Rb/p107 degradation. We 
envisioned a scenario where CTSL-mediated degradation of Rb and p107 alters the balance 
between the pocket family proteins, leading to increased formation of p130/E2F4 complexes, 
which can in turn mediate transcriptional repression of BRCA1 and RAD51 and this inhibit HR. To 
test our model we overexpressed CTSL in wild-type MEFs and monitored the levels of Rb family 
members, BRCA1 and RAD51. Indeed, we found that upregulation of CTSL was associated with 
a substantial decrease in pRb and p107, with little effect on p130, mirroring the phenotype 
observed in lamins-deficient cells. These results demonstrate a novel role for CTSL in the 
regulation of the retinoblastoma family of tumor suppressors. However, altering the levels of 
these proteins was not sufficient to induce transcriptional repression of BRCA1 or RAD51, 
suggesting that lamins have additional roles in the regulation of transcription of these genes.  
 
Upregulation of CTSL is featured in a variety of cancers. Given the important role of Rb 
as a tumor suppressor, it is likely that overexpression of CTSL represents yet another mechanism 
by which tumor cells escape cell-cycle arrest. Furthermore, upregulation of CTSL and the ensuing 
degradation of 53BP1 would compromise C-NHEJ and lead to genomic instability. Thus 
upregulation of CTSL increases genomic instability by hindering DDR, yet impedes one of the 
major cell cycle checkpoints responsible for ensuring genomic stability [247] by promoting 
degradation of pRb. This double-blow to the integrity of the genome supports a significant role for 
CTSL in tumorigenesis. Importantly, we have not identified the mechanism by which loss or 
mutation of A-type lamins leads to transcriptional upregulation of CTSL. Given that alterations in 
A-type lamins causes gross alterations in 3D distribution of chromatin, it is possible that increased 
transcription of CTSL is a result of altered nuclear localization. It will be interesting to manipulate 






While A-type lamins are implicated in wide a variety of human diseases, including 
premature aging syndromes and cancer, little is known about the molecular mechanisms that 
contribute to their pathogenesis. Here, I have presented our findings that loss of A-type impacts 
telomere homeostasis and the two major pathways of repair of DSBs, NHEJ and HR. Additionally, 
our studies on A-type lamins have led to the discovery of CTSL as a novel regulator of 53BP1 
and the retinoblastoma pocket family proteins, suggesting a fundamental role for CTSL in the 
regulation of cell cycle progression and DNA repair. These novel findings provide a significant 
contribution to understanding the molecular mechanisms that contribute to genomic stability, and 
advance our understanding of cancer, aging and laminopathic mutations  
 
The findings that depletion of A-type lamins impairs DNA repair and induces 
radiosensitivity, along with clinical data indicating that lamins expression can affect prognosis in 
certain malignancies, introduces the possibility of using these proteins as targets for cancer 
therapeutics. In addition, identification of 53BP1, RAD51 and BRCA1 as molecular targets of A-
type lamins provides new tools to screen disease-associated mutations in the LMNA gene for 




















Lmna+/+ and Lmna-/- MEFs and adult fibroblasts were generated in the laboratory of Colin 
L Stewart as described by Sullivan et al [151]. Rb family-deficient MEFs were generated in the 
laboratory of Julien Sage (Stanford University, CA). MCF-7 and U2OS cells were obtained from 
ATCC (Manassas, VA). The MCF-7 DR-GFP cell line was previously described [248]. All lines 
were maintained in DMEM-Glutamax (Invitrogen) supplemented with 10% bovine growth serum, 
antibiotics, and antimycotics. For cycloheximide and proteasome inhibitor treatments, 0.5  106 
cells were cultured for 6 h in media containing 10 g/ml cycloheximide, 30 M MG-132 (EMD 
Biochemicals) or EtOH as control. 
Chromatin Immunoprecipitation (ChIP) 
ChIP analyzes were carried out exactly as described [54]. Chromatin extracted from Cells 
cultured to 70-80% confluency in 150mm plates and subjected to immunoprecipitation with 
various antibodies. Chromatin isolation: Adherent cells were treated for 15minutes at room 
temperature (rt) with 1% formaldehyde/PBS to crosslink protein and DNA. Crosslinking was 
terminated by the addition of glycine (final concentration 0.125 – 0.150 M) for 5 minutes. Cells 
were then washed once with PBS, and then transferred (by scraping with ice-cold 
PBS/PMSF/protease inhibitor cocktail) to 50ml falcon tubes. Cells were kept on ice from this point 
on. Cells were pelleted and the lysed with a solution of lysis buffer (below) with PMSF/protease 
inhibitors for 10 minutes on ice, and then sonicated to obtain DNA fragments between 250 and 
1000 base pairs. Sonication was done in a bioruptor at 30 second intervals for 15 minutes at high. 
After centrifugation of the sonicated mixture (14, 000 rpm for 15 minutes at rt), the supernatant 
containing the chromatin was collected and the pellet was discarded. 
 
 Immunoprecipitation: 200 μl of the lysates was transferred to a 2ml eppendorf tube and 
diluted 1/10 in dilution buffer (below) with PMSF/protease inhibitors and then pre-cleared 
with 40μl of salmon sperm/protein A/G agarose beads (Upstate# 16-157) for 5 hours at 
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4oC on a rotating platform. The supernatant was recovered by centrifuging the mixture at 
rt for 4 minutes, 4000 rpm. Next, 4μg of the antibody of interest was added to the 
solution, followed by incubation at 4oC for 1hr. 60 μl protein A/G beads was added to the 
solution, which was then incubated at 4oC overnight on a rotating platform. The solution 
was centrifuged and the supernatant stored on ice as the unbound fraction for later use 
as inputs. The pelleted fraction, containing the beads, was washed with a series of wash 
buffers (detailed below): once in low salt immune complex wash buffer, once in high salt 
immune complex wash buffer, once in LiCl immune complex wash buffer, twice in TE 
buffer. 2ml of the respective buffers was used for the each wash, which was done for 
4minutes at rt on a rotating platform. Elution of the immune complexes was done by 
adding 250μl of elution buffer (below), vortexing at rt slowly for 15, followed by 
centrifugation at 4000 rpm for 4 minutes. The eluate was transferred to a separate tube, 
and the elution procedure repeated once more. The eluates were combined to get 
≈500ul containing the bound fraction. We then reversed the crosslinks by adding 20μl of 
5M NaCl and incubating at 65oC overnight (inputs were included at this step).  
 
DNA Recovery: To remove RNA and proteins we added 10μl of 0.5M EDTA, 20 μl 1M 
Tris-HCl pH 6.5, 2 μl RNase (10 μg/ μl), 2 μl proteinase K (20 μg/ μl) to each sample, 
and incubated at 45oC for 1hour. DNA was then recovered by phenol/chloroform 
extraction and ethanol precipitation. 500 μl chloroform: isoamyl alcohol 24:1 was added 
and the solution vortexed on high, then centrifuged at rt for 5 minutes at 10, 000 rpm in a 
tabletop centrifuge. The supernatant was transferred to a 2ml eppendorf tube in which 
we added 50 μl 5M NaCl, 1.5 ml ethanol and 1 μl glycogen, followed by incubation at -
20oC for an hour to precipitate the DNA. After centrifuging this mixture for 15 minutes at 
14, 000 rpm we washed the pellet with 70% ethanol. The pellet was allowed to air dry 
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and then resuspended in 30 μl TE buffer. DNA was then slot-blotted on a Hybond N+ 
membrane and hybridized to a telomeric probe (gift from T de Lange, Rockefeller 
University, NY, USA) or a major satellite probe. The quantification of the signal was done 
using the ImageQuant software (Molecular Dynamics). We calculated the amount of 
telomeric or pericentric DNA immunoprecipitated relative to the signal of the 
corresponding inputs. In all cases, we represented the ChIP values as a percentage of 
the total input telomeric DNA, therefore correcting for differences in the number of 
telomere repeats.  
 
The following antibodies were used for chromatin immunoprecipitation:  
Anti-H3K9me3 (#07-442, Upstate); anti-H4K20me3 (#07-463, Upstate); anti-TRF1 (T1948, 
Sigma); anti-TRF2 (#05-521, Upstate); or anti-lamin A/C (SC-6215, Santa Cruz).  
 
ChIP solutions: 
Lysis buffer: 1% SDS, 10mM EDTA, 50 mM Tris-HCl pH8, protease inhibitor cocktail. 
Dilution buffer: 1.1% Triton X-100, 0.01% SDS, 1.2 mM EDTA pH 8.0, 167 mM NaCl, 16.7 mM 
Tris-HCl pH 8, protease inhibitor cocktail. 
Low salt immune complex wash buffer: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM Tris-HCl 
pH 8, 150 mM NaCl. 
High salt immune complex wash buffer: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM Tris-
HCl pH 8, 500 mM NaCl. 
LiCl immune complex wash buffer: 0.25M LcCl, 1% NP-40, 1% deoxycholateNa, 1mM EDTA, 10 
mM Tric-Hcl ph 8. 
Elution buffer: 1% SDS, 50 mM NaHCO3 
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Immunoprecipitation, Immunoblotting and Immunofluorescence 
Immunoprecipitation of Rb family members. 
Cells were lysed in RIPA buffer (0.15 M NaCl, 0.05 M Tris–HCl pH 7.2, 1% Triton-X 100, 
1% sodium deoxycholate, and 0.1% SDS), sonicated and 1 mg of total protein 
immunoprecipitated with antibodies bound to protein A-agarose beads: Rb (IF18), p107 (C-18), 
and p130 (C-20) from Santa Cruz. Protein detection was carried out using antibodies against Rb 
(BD Pharmingen), p107 and p130 (Santa Cruz). 
 
Immunoblotting 
For immunoblotting, cells were lysed in RIPA buffer. Protein detection was carried out 
using the following antibodies: Lamin A/C (SC-6215, 20681 Santa Cruz), actin (Clone C4, MPB), -
tubulin (Sigma), TRF1 (gift from Maria A Blasco), TRF2 (#05-521, Upstate), POT1 (gift from Qin 
Yang), 53BP1 (Bethyl Laboratories, A300-272A), MDC1 (gift from Junran Zhang), ATM 
(GTX7107, GeneTex), DNA-PKcs (MS-423-P, NeoMarkers), Mre11 (Novus, MB100-142), Nbs1 
(Cell Signaling, 3002B), Ku70 (SC-1486, Santa Cruz), H2AX (Upstate, 07-164), H2AX (Upstate, 
07-164), ERCC1 (SC-17809, Santa Cruz), RPA2 (Calbiochem, NA18), actin (Clone C4, MPB), β-
tubulin (Sigma), and BRCA1 (Santa Cruz-6954). 
 
Immunofluorescence 
Immunofluorescence was performed with antibodies: γH2AX (1:600, Upstate 
Biotechnology), 53BP1 (1:600, Novus Biologicals NB100-304), RAD51 (1:100, Santa Cruz sc-
8349), or RPA2 (1:100 Calbiochem, NA18). Cells were grown on coverslips until 70–80% 
confluent and irradiated with a dose of either 0.5 Gy (53BP1 and γH2AX) or 8 Gy (RAD51). At 
different times post-IR, cells were fixed with 3.7% formaldehyde and 0.2% Triton-X100 for 10 min 
at RT. Cells were blocked for 1 h at 37°C with 1% goat serum or BSA in PBS and incubated with 
primary antibodies for 1 h at 37°C. Secondary antibody incubations were performed for 1h at 
37°C using Alexa- and Cy3-labeled antibodies. Slides were counterstained using DAPI in 
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Vectashield (Vector). Fluorescent images were taken using a Nikon 90i upright microscope or 
with a confocal microscope Zeiss L510. 
 
X-ray irradiation  
This was done using a PANTAK pmc1000 X-ray machine with a 0.1 Cu+ 2.5 AL filter at a 
dose rate of 1.1 Gy/min. For immunofluorescence studies cells were irradiated with 0.5 Gy or 8 
Gy, and for comet assays cells were given 8 Gy. 
Terminal restriction fragment (TRF) analysis 
We prepared cells in agarose plugs and carried out TRF analysis as described [249]. 
Cells were washed with 1X PBS, pelleted by centrifugation, resuspended in 50 μl PBS and 
incubated at 50oC for 5 minutes. 50 μl of 2% low-melt agarose/PBS (previously heated at 50oC) 
was added and the mixture (100 μl) incubated for 5 minutes at 50oC.This mixture was then 
transferred to a disposable plug mold (Bio-Rad #170-3713) and allowed to solidify by cooling at rt 
for 5 minutes and then at 4oC for 15 minutes. The plugs were then transferred to eppendorf tubes 
and 500 μl of proteinase K buffer (2mg/ml proteinase K) added to the tube, which was incubated 
at 4oC overnight. The next day, plugs were washed with TE buffer (4 x 1 hour each). PMSF was 
added to the third and fourth washes to inactivate the proteinase K. Samples were then stored at 
4oC in TE buffer until digestion. Plugs were washed in water for 1 hour, and then equilibrated for 
1 hour in MboI enzyme buffer. Next, the plugs were incubated in 0.3 ml restriction enzyme buffer 
containing 50U of MboI enzyme solution overnight at 37oC. Following digestion the plugs were 
washed 30 minutes with water and 30 minutes with 0.5X TBE buffer. Finally, pulse-field gel 
electrophoresis was performed using 1% low-melt agarose in 0.5X TBE buffer for 23 hours at 6 
V/cm2. Following electrophoresis, the gel was denatured 3 x 30 minutes and neutralized 3 x 30 
minutes (solutions below). The Whatman TurboBlotter™ system was used to transfer the DNA to 
nylon membrane. Finally, DNA was crosslinked to the membrane using the Stratalinker® UV 
crosslinker, and treated with a (TTAGGG)n probe. 
 





Denaturing solution: 0.5M NaOH, 1.5M NaCl in water 
Neutralizing solution: 0.5M Tris-HCl, 1.5M NaCl in water, adjusted to pH 7.0 
Quantitative Fluorescence in Situ Hybridization (Q-FISH)  
We prepared metaphase stage chromosomal spreads for Q-FISH and hybridized them as 
described [250].  
 
Metaphase preparation:  
Cells were cultured in 10mm dishes to 70% confluence. Colcemid (Sigma #D1925) was 
added to the culture media (100 μl to every 10 ml media) for 4 hours to arrest cells in metaphase. 
After collecting the culture media, we washed with 1X PBS (which was also collected), and 
collected the trypsinized cells. All the fractions were combined and centrifuged to pellet the cells. 
Supernatant was the aspirated to leave ≈1 ml of media + cell pellet, which was resuspended by 
gentle flicking. 9 ml of pre-heated (37oC) hypotonic buffer (0.56% KCl) was added then to the cell 
suspension, which was incubated in a 37oC water bath to allow hypotonic swelling of the cells. A 
small amount (≈3 drops) of fixing solution (3:1 methanol: acetic acid) was added and the cells 
were pelleted at 4oC by centrifugation. Cells were kept on ice from this point onwards. After 
aspirating the supernatant to leave ≈1ml, the cells were resuspended by gentle flicking and 11ml 
fixing solution was added dropwise. The suspension was centrifuged once more to pellet the cells 
and fixing solution added in a similar manner. This mixture was stored at -20oC until hybridization.  
 
Metaphase hybridization:  
Cells were pelleted, resuspended in 1ml fresh fixing solution, added to microscope slides 
and allowed to dry at rt overnight. Next, we washed the slides 3 x 5minutes in 1X PBS, fixed in 
4$formaldehyde/PBS and washed 3 x 5 minutes in 1X PBS. Slides were treated with pre-heated 
acidified pepsin (below) for 10 minutes at 37oC and washed 3 x 5 minutes in 1X PBS. After a 
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second treatment with formaldehyde and PBS washes, the slides were dehydrated by incubating 
for 5 minutes each in 70%, 90%, then 100% ethanol and allowed to air dry. Two drops (10 μl 
each) of the probe mixture (below) was then added to each slides and a coverslip applied. Slides 
were then heated at 80oC for 3 minutes for denaturation, and incubated in a wet chamber away 
from light for 2 hours at rt. Following incubation, the slides were washed 2 x 15 minutes in 
buffer#1 (below), and then 3 x 5 minutes in buffer#2 (below). Finally, slides were dehydrated in 
ethanol as before, air dried and DNA counterstained with DAPI solution. Fluorescent images were 
taken using a Nikon 90i upright microscope and intensity of telomere fluorescence analyzed using 
the TFL-Telo program (gift from P Lansdorp, Vancouver, Canada) [251]. Images and telomere 
fluorescence values were obtained from more than 50 metaphases in all cases. 
 
Q-FISH Solutions 
Pepsin solution: 200ml water, 200mg pepsin, 168 μl concentrated HCl (stock 12M). 
Probe solution: 2.5μl Tris 1M pH7.4, 21.4μl MgCl2 buffer, 175μl deionized formamide, 5.0μl 
telomere probe 25 μg/ml, 12.5μl blocking reagent, 33.6μl distilled water. 
PNA telomere probe: TelC-Cy3 (Panagene catalog# F1002-5) 
Blocking reagent: 10g Boehringer reagent in 100ml maleic acid buffer pH7.5 
Maleic acid buffer: 100 mM maleic acid, 150 mM NaCl pH 7.5 
MgCl2 buffer: 25 mM MgCl2, 9mM citric acid, 82 mM Na2HPO4, adjusted to pH 7.0 
Buffer #1: 280 ml Formamide, 4 ml Tris 1M pH 7.2, 4 ml BSA (stock of 10% in water), 112 ml 
distilled water. 
Buffer #2: 0.08% tween-20 in TBS 
Viral Transductions 
Viral transduction with dominant-negative TRF2, lamin A, lamin C, and shRNAs (shLmna 
and shLuciferase). A dominant-negative TRF2 mutant (TRF2∆B∆M) cloned into the pLPC vector 
(gift from Titia de Lange, Rockefeller University) along with packaging and envelope plasmids 
pUMVC and pCMV-VSV-G (provided by Sheila Stewart, Washington University) were transfected 
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in 293T packaging cells using Fugene 6® (Roche Applied Science). Virus-containing media 
collected from the 293T cells and used to infect the target cells. For retroviral transductions the 
infection was repeated 24 h later. The same procedure was used to introduce lamins A/C into A-
type lamins depleted cells. Retroviral vectors for expression of lamins A/C were a gift from Brian 
Kennedy (University of Washington, Seattle, WA). GFP was used to monitor the efficiency of 
293T transfection and MEF infection. Lentiviral transduction of shRNA sequences cloned into 
pLKO was carried out in the same manner, using the packaging plasmid pHR’8.2∆R and the 
envelope plasmid pCMV-VSV-G. Infected cells were subjected to immunoblotting after selection 
to ensure depletion or overexpression of the target proteins. shLmna and shLuciferase were a gift 
from Didier Hodzic (Washington University, St Louis, MO), sh53BP1 was a gift from Barry 
Sleckman (Washington University, St Louis, MO). 53BP1 expression plasmid was obtained from 
Addgene. 
Immuno-FISH 
Cells were fixed for 10 min in 3.7% formaldehyde/0.2% Tx-100/PBS at RT, followed by 
three washes in PBS. After blocking in 10% BGS/PBS for 1 h, cells were incubated with anti-
H2AX antibody 1 h at 37°C, washed three times and incubated with secondary antibodies. After 
washing extensively in PBS, cells were processed for FISH. Cells were fixed in 3.7% 
formaldehyde/PBS for 10 min at RT, washed in PBS, dehydrated in ethanol (70%, 90%, 100% 
ethanol, 5min each), and air dried. Hybridization solution containing the cy3-labeled telomeric 
probe was added to coverslips, which were heated to 80°C for 10 min, and incubated for 3 h in 
the dark at RT. Coverslips were washed twice for 15 min in washing solution, and three times in 
PBS. Cells were counterstained with DAPI and coverslips mounted on slides. 
CO-FISH 
CO-FISH analysis was carried out as described [175]. Briefly, cells were cultured in 20 M 
BrdU for 22 h and 0.1 g/ml colcemid was added for the last 4 h to enrich for mitotic cells. 
Metaphase stage chromosomal spreads were prepared as for Q-FISH [250]. The slides were 
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treated with RNase A (0.5 g ml-1 for 10 min at 37°C), stained with Hoechst 33258 in 2X SSC for 
15 min at RT and exposed to 365 nm UV light for 30 min. Exonuclease III (3 U/l) treatment for 20 
min at RT was used to digest the BrdU-labeled strands. The slides were then processed as for Q-
FISH but with two different probes added sequentially. Hybridizations were carried out first with 
the G-rich probe (labeling the leading strand) followed by the C-rich probe (labeling the lagging 
strand). 
Histones.  
Histones were purified by acid extraction as detailed by Shechter et al [252]. Histone 
modifications were detected by immunoblotting using anti-H3K9me3 and anti-H4K20me3 
(Upstate). 
Telomerase Activity 
Telomerase activity was determined using the TeloTAGGG Telomerase PCR ELISA* Kit 
(Roche) following manufacturer's instructions. 
Comet Assays 
Neutral comet assays were performed using CometSlide assay kits (Trevigen). Cells 
were irradiated with 8 Gy, and incubated at 37ºC for different periods of time (0, 30, 60, 90, 120 
and 150 min) to allow for DNA damage repair. Cells were embedded in agarose, lysed and 
subjected to neutral electrophoresis. Before image analysis, cells were stained with ethidium 
bromide and visualized under a fluorescence microscope. Single-cell electrophoresis results in a 
comet-shaped distribution of DNA. The comet head contains high molecular weight and intact 
DNA, and the tail contains the leading ends of migrating fragments. Olive comet moment was 
calculated by multiplying the percentage of DNA in the tail by the displacement between the 
means of the head and tail distributions, as described 60. We utilized the program CometScore™ 
Version 1.5 (TriTek) to calculate Olive Comet Moment. A total of 25 to 30 comets were analyzed 
per sample in each experiment. 




X-ray irradiation  
This was done with a PANTAK pmc1000 X-ray machine with a 0.1 Cu+ 2.5 AL filter at a 
dose rate of 1.1 Gy/min. For immunofluorescence studies cells were irradiated with 0.5 Gy or 8 
Gy, and for comet assays cells were given 8 Gy. 
Homologous recombination assays  
Proficiency of HR is monitored by using a chromosomally integrated HR reporter 
substrate, DR-GFP, in MCF-7 cells 58. The DR-GFP substrate consists of two tandem GFP 
sequences that have been mutated to abrogate expression of GFP and an I-SceI recognition site 
in one sequence. Transient expression of the I-SceI produces a DSB at the recognition site. 
Repair of this break by intragenic HR with the downstream GFP sequence as the homology 
substrate results in restoration of a functional GFP gene. Thus, expression of GFP is readout of 
successful HR 58. MCF-7 DR-GFP cells were transfected with an I-SceI expressing plasmid. 
After 48 hours, flow cytometry was used to determine the percent of cells expressing GFP as an 
indication of successful HR.  
Colony formation assays  
Clonogenic analysis was performed as described. Briefly, cells were plated in p60 culture 
dishes to facilitate formation of 30-40 colonies per plate and allowed to become adherent by 
incubating at 37°C for 2-3 hours. Cells were immediately treated with 0, 2, 4, or 6 Gy of ionizing 
radiation, and allowed to grow undisturbed for 7-10 days. Colonies were then counted and the 
surviving fractions calculated. Colony formation experiments were done three times, with triplicate 
samples within each experiment.  
Quantitative real time PCR  
For chapter 2 Quantitative real-time PCR was carried out on a MyiQ Detection system 
(BIO-RAD, California, USA) using Taqman Universal PCR Master Mix (PE Applied Biosystems, 
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California, USA). The cDNA was generated from 1 g of total RNA using Geneamp RNA PCR kit 
(PE Applied Biosystems) following manufacturer's instructions. 53BP1 and GAPDH expression 
was determined using Taqman Gene expression assays (Mm00658689_m1 and 
Mm99999915_g1, respectively, PE Applied Biosystems). For the analysis, all reactions (in 
triplicate) were carried out by amplifying target gene and endogenous controls in the same plate. 
Relative quantitative evaluation of target gene was determined by comparing the threshold 
cycles.  
 
For chapter 3. Quantitative real-time PCR was performed using the 7900HT Fast Real-
Time PCR system (Applied Biosystems) with the Taqman® Universal PCR Master Mix (Applied 
Biosystems, California, USA). Generation of cDNA was carried out by reverse transcription of 1μg 
total RNA using the GeneAmp® RNA PCR kit, also from Applied Biosystems. RAD51, BRCA1 
and RPA2 transcripts were detected by TaqMan® Gene Expression Assays (Hs00153418_m1, 
Hs01556193_m1, and Hs00358315_m1 respectively). All PCR reactions were done in triplicate 
within experiments to amplify endogenous target genes, with 18S controls in the same plate. Data 
was analyzed by relative quantitation.  
 
Statistical analysis 
A 'two-tailed' Student's t-test, 'two-samples of equal variance' was used to calculate 
statistical significance of the observed differences in telomere length. Microsoft Excel v.2001 and 
Graphpad Instat v3.05 were used for the calculations. A paired t-test to determine statistical 
significance was alternatively used when indicated. In all cases, differences were considered 
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Distribution of the telomeres 
To analyze the distribution of the telomeres we have chosen as metric; the shortest 
distance from the telomere to the edge of the convex hull [1], see figure 1. The 
fluorescent images of the telomere channel have been deconvolved, using in-house 
deconvolution software written in MatLab (The Mathworks, Natick, MA, USA). The 
MAPPG algorithm is chosen for devolving as described in [2]. The point spread function 
(PSF) used is an analytical PSF implemented according to [3]. After deconvolution, four 
steps are taken: 1. localization of the telomere signals, 2. computation of the convex hull, 
3. computation of the distance transform within the convex hull, 4. extraction of the 
distance and intensity of the telomere fluorescent signal. All analyses have been done in 
3D, but for clarification we have shown an example of the algorithms in 2D in figure 1. 
To determine the position of the telomeres we have used TeloView [4]. This program is 
especially designed to locate telomere FISH signals in images of fluorescently labeled 
nuclei. It uses a set of image processing algorithms from DIPimage, developed at the 
Quantitative Imaging Group (TU-Delft, The Netherlands, http://www.diplib.org) [5]. 
Both TeloView and DIPimage are implemented in MatLab. localization of the telomere 
signal, is performed as described in [6]. In short: after a scale space method, which 
enhances the contrast of the signal, a threshold is chosen to segment the telomere signals. 
Using the graphical interface of TeloView missed signals can be added or false signals 
can be removed. The second step is the calculation of the convex hull [1], which is the 
smallest convex volume enclosing all the found telomeres. For the next step we transform 
the hull into a distance matrix using the  Euclidian Distance Transform (EDT) [7, 8]. The 
EDT transforms the binary image (the convex hull image) into an image where the 





Figure 1:  Cartoon showing the distance measure. The red dots represent the telomere signals. The red 
line represents the convex hull surrounding the telomeres. For every telomere we measure, ri; 
the shortest distance from the surface of the convex hull to the telomere. 
 
 
Distribution of the telomere intensity 
The fourth step is to calculate the integrated intensity of the telomere. The integrated 
intensity is proportional to the size of the telomere because the size is proportional to the 
amount of fluorochrome that is attached to the telomere and therefore to the telomere 
length [9]. We create a binary mask with the watershed algorithm [10] of the image data, 
g, convolved with a Gaussian profile with 1 pixelσ = for noise reduction. Now the 
telomere coordinates (xn, yn, zn), determined above, tell us which objects in this mask are 
telomere regions. Simply integrating intensities in these regions will also give the wrong 
answer because background pixels are not excluded from these regions and will bias our 
calculations. Our solution is to calculate the integrated intensity in a region of interest 
with (xn, yn, zn) as middle point within this mask resulting from the watershed. The region 
of interest is a small sphere, with radius r, convolved with a Gaussian profile with width 
1 pixelσ =  in the lateral and 3 pixelsσ = in the axial direction, which results in an 
elongated sphere. We will call this region of interest, which is gray-scale, spheregray and 
the region from the watershed, which is binary, we will call mask. The next binary region 
with which we work with is spherebin. This is a binary sphere with radius 3r σ+  (with 
1 or 3 pixelsσ =  depending on the direction). Now we define the mean of the grey values 
of g at the coordinates where mask has value one and spherebin has value zero as our 
background level, b. Our signal image, gsignal, becomes: 
 
 ( )signalg g mask b= −  (1) 
 
We normalize both spheregray and gsignal for their maximum value and calculate their 

















∑  (2) 
 
This process starts with . First we rename ε1r = new: 
 
 old newε ε=  (3) 
 
Now we grow the region by using 1r r= +  for the next iteration and calculate εnew again. 
The iterative process is stopped when 
 
 new oldε ε>  (4) 
 
The integrated intensity, In, for the nth telomere is now 
 
 (n signal bin )I g sphere=∑  (5) 
 
In figure 2 we show a flow chart of the algorithm. 
 
Figure 2:  Flow chart showing the algorithm to calculate the integrated intensity of a telomere 
signal. The basic idea is to calculate the integrated intensity in a growing region 
of interest until no more intensity is added. The growing is confined by a mask 
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